☰

Eric K. Waller, Ph.D. - Publications

Affiliations: 
2014 Environmental Science, Policy, and Management University of California, Berkeley, Berkeley, CA, United States 
Area:
Environmental Sciences, Ecology Biology, Remote Sensing
Tree Info Similar researchers PubMed Report error

5/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Baldocchi D, Waller E. Winter fog is decreasing in the fruit growing region of the Central Valley of California Geophysical Research Letters. 41: 3251-3256. DOI: 10.1002/2014Gl060018  0.443
2011 Waller EK, Harris WA, Devine S, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Gurgol C, Logan BR, Confer DL, et al. Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201 Blood. 118: 1004-1004. DOI: 10.1182/Blood.V118.21.1004.1004  0.315
2004 Arellano ML, Moore SG, Kudchadkar R, Flowers CR, Langston AA, Lonial S, Lechowicz MJ, Waller EK. Predictors of More Rapid Lymphoid Reconstitution after Allogeneic Transplantation. Blood. 104: 3159-3159. DOI: 10.1182/blood.v104.11.3159.3159  0.322
2002 Waller EK, Rosenthal H, Sagar L. DC2 effect on survival following allogeneic bone marrow transplantation Oncology (Williston Park, N.Y.). 16: 19-26. PMID 11829279  0.307
2000 Waller EK, Boyer M. New strategies in allogeneic stem cell transplantation: Immunotherapy using irradiated allogeneic T cells Bone Marrow Transplantation. 25. PMID 10933181 DOI: 10.1038/sj.bmt.1702347  0.307
Low-probability matches (unlikely to be authored by this person)
2004 Giralt S, Logan B, Zhang M, McGaha O, Ballen K, Emmanouilides C, Nath R, Parker PM, Porter D, Sandmaier B, Waller E, Barker J, Pavletic S, Weisdorf D. Non-Ablative or Reduced Intensity Conditioning Regimens with Volunteer Unrelated Donor Progenitor Cell Transplantation. Blood. 104: 2751-2751. DOI: 10.1182/Blood.V104.11.2751.2751  0.297
2004 Giver CR, Li JM, Hossain MS, Lonial S, Waller EK. Reconstructing immunity after allogeneic transplantation. Immunologic Research. 29: 269-82. PMID 15181288 DOI: 10.1385/IR:29:1-3:269  0.297
2018 Wang Y, Li Y, Li J, Li J, Waller EK. Donor Plasmacytoid Dendritic Cells Home to the Thymus of the Transplant Recipient and Limit Graft Versus Host Diseases through Production of Vasoactive Intestinal Polypeptide Blood. 132: 4518-4518. DOI: 10.1182/blood-2018-99-119172  0.297
2003 Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, Lonial S, Boyer MW, Waller EK. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects Biology of Blood and Marrow Transplantation. 9: 616-632. PMID 14569558 DOI: 10.1016/S1083-8791(03)00229-5  0.297
2000 Mittelstaedt SJ, Montes RO, Boyer MW, Waller EK. Fludarabine treated donor lymphocytes enhance immune reconstitution without gvhd in allogeneic bone marrow transplantation Blood. 96.  0.292
2011 Hossain MS, Jaye DL, Pollack BP, Farr AB, Roback J, Gewirtz AT, Waller EK. Flagellin, a TLR5 Agonist, Reduces GvHD in Allogeneic HSCT Recipients While Enhancing Anti-Viral Immunity: A Novel Therapeutic Approach Blood. 118: 144-144. DOI: 10.1182/Blood.V118.21.144.144  0.292
2018 Waller EK, Villarreal ML, Poitras TB, Nauman TW, Duniway MC. Landsat time series analysis of fractional plant cover changes on abandoned energy development sites International Journal of Applied Earth Observation and Geoinformation. 73: 407-419. DOI: 10.1016/J.Jag.2018.07.008  0.291
2009 Lu Y, Harris W, Li J, Waller EK. Donor BM Dendritic Cells Expressing IDO Limit Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplant. Blood. 114: 1331-1331. DOI: 10.1182/blood.v114.22.1331.1331  0.291
2019 Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. Blood Advances. 3: 2250-2263. PMID 31345792 DOI: 10.1182/Bloodadvances.2018029892  0.29
2005 Hossain MS, Roback JD, Lezhava L, Hillyer CD, Waller EK. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 11: 169-180. PMID 15744235 DOI: 10.1016/j.bbmt.2004.12.332  0.29
2014 Waller EK, Giver CR, Rangaraju S, Swimm A, Sharma A, Qayed M, Defilipp Z, Kalman D. Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation Blood. 124: 2420-2420. DOI: 10.1182/Blood.V124.21.2420.2420  0.29
2009 Li JM, Southerland LT, Lu Y, Darlak KA, Giver CR, McMillin DW, Harris WA, Jaye DL, Waller EK. Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation. Journal of Immunology (Baltimore, Md. : 1950). 183: 7799-809. PMID 19933853 DOI: 10.4049/jimmunol.0900155  0.289
2013 Rangaraju S, Choi J, Giver CR, Waller EK. Pharmacological Inhibition Of Semi-Direct Alloantigen Presentation and The Generation Of Cross-Dressed Antigen Presenting Cells: A Novel approach To Limit Graft Versus Host Disease Following Allogeneic Hematopoetic Stem Cell Transplantation Blood. 122: 294-294. DOI: 10.1182/blood.v122.21.294.294  0.289
2014 Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2365-72. PMID 24982459 DOI: 10.1200/Jco.2013.54.4577  0.289
2002 Kean LS, Durham MM, Adams AB, Hsu LL, Perry JR, Dillehay D, Pearson TC, Waller EK, Larsen CP, Archer DR. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood. 99: 1840-9. PMID 11861303 DOI: 10.1182/Blood.V99.5.1840  0.289
2018 Hassan M, Antonova AU, Li JM, Hosoba S, Rupji M, Kowalski J, Perricone AJ, Jaye DL, Marsh H, Yellin M, Devine S, Waller EK. Flt3L treatment of bone marrow donors increases graft plasmacytoid dendritic cell content and improves allogeneic transplant outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30503387 DOI: 10.1016/j.bbmt.2018.11.029  0.288
2009 Yu X, Valenzuela J, Iclozan C, Hossain M, Hopewell E, Bronk C, Wang J, Celis E, Engelman R, Waller EK, Blazar BR, Beg A. Targeting PKCtheta Inhibits Alloreactivity and Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia and Anti-Infection Activities. Blood. 114: 2458-2458. DOI: 10.1182/Blood.V114.22.2458.2458  0.288
2006 Li JM, Gorechlad J, Larsen CP, Waller EK. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1239-49. PMID 17162205 DOI: 10.1016/J.Bbmt.2006.08.038  0.288
2016 Li J, Li J, Waller EK. Presence of Vasoactive Intestinal Polypeptide Signaling in Plasmacytoid Dendritic Cells Improves Survival in a Murine Allo-BMT Model Blood. 128: 2154-2154. DOI: 10.1182/blood.v128.22.2154.2154  0.288
2011 Darlak K, Wang Y, Li J, Waller EK. Enrichment of Donor Plasmacytoid Dendritic Cells in Bone Marrow Allografts Enhances Graft Vs. Leukemia Activity and Th1 Polarization of Donor T Cells Blood. 118: 4701-4701. DOI: 10.1182/BLOOD.V118.21.4701.4701  0.286
2013 Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, ... ... Waller EK, et al. Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 625-31. PMID 23333532 DOI: 10.1016/j.bbmt.2013.01.009  0.286
2006 Li JM, Giver CR, Waller EK. Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT Experimental Hematology. 34: 895-904. PMID 16797417 DOI: 10.1016/j.exphem.2006.03.008  0.285
2004 Waller EK, Giver CR, Rosenthal H, Somani J, Langston AA, Lonial S, Roback JD, Li JM, Hossain MS, Redei I. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood Cells, Molecules & Diseases. 33: 233-7. PMID 15528137 DOI: 10.1016/j.bcmd.2004.08.009  0.285
2004 Li JM, Waller EK. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 10: 540-551. PMID 15282532 DOI: 10.1016/j.bbmt.2004.05.007  0.285
2013 Koura DT, Horan JT, Langston AA, Qayed M, Mehta A, Khoury HJ, Harvey RD, Suessmuth Y, Couture C, Carr J, Grizzle A, Johnson HR, Cheeseman JA, Conger JA, Robertson J, ... ... Waller EK, et al. In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1638-49. PMID 24047754 DOI: 10.1016/J.Bbmt.2013.09.003  0.285
2008 Hossain M, Gewirtz AT, Roback JD, Waller EK. Flagellin, a TLR5 Agonist, Down-Regulate CD62L on Donor T Cells and Limit GvHD in Allogeneic Hematopoietic Stem Cell Transplantation Blood. 112: 3521-3521. DOI: 10.1182/Blood.V112.11.3521.3521  0.285
2003 Roback JD, Hossain MS, Lezhava L, Gorechlad JW, Alexander SA, Jaye DL, Mittelstaedt S, Talib S, Hearst JE, Hillyer CD, Waller EK. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. Journal of Immunology (Baltimore, Md. : 1950). 171: 6023-31. PMID 14634114 DOI: 10.4049/Jimmunol.171.11.6023  0.285
2015 Chen Y, Le-Rademacher J, Kiefer DM, Hamadani M, DiPersio JF, Litzow MR, Craig M, Horwitz ME, Artz A, McClune B, Waller EK, Fernandez HF, Duong HK, Kobusingye H, Proue M, et al. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies Blood. 126: 389-389. DOI: 10.1182/BLOOD.V126.23.389.389  0.285
2011 Hossain MS, Jaye DL, Pollack BP, Farris AB, Tselanyane ML, David E, Roback JD, Gewirtz AT, Waller EK. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 5130-40. PMID 22013117 DOI: 10.4049/Jimmunol.1101334  0.284
2008 Li J, Darlak KA, Lu Y, Giver C, Harris W, Jaye DL, Waller E. CD11b− Donor Dendritic Cells Enhance Donor T-Cells’ Th1 Polarization and Graft Versus Leukemia Activity in Allogeneic Hematopoietic Stem Cell Transplantation Blood. 112: 1252-1252. DOI: 10.1182/BLOOD.V112.11.1252.1252  0.284
2019 Zhu J, Wang Y, Li J, Li Y, Ulezko Antonova A, Giver CR, Li J, Wang S, Waller EK. Transplanted Vasoactive Intestinal Peptide-Secreting Donor Plasmacytoid Dendritic Cells Migrate to Lymphoid Organs and GvHD Target Organs Blood. 134: 1918-1918. DOI: 10.1182/blood-2019-129628  0.284
2002 Redei I, Langston AA, Lonial S, Cherry JK, Allen AJ, Hamilton E, Jones M, Bartlett VM, Waller EK. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors. Bone Marrow Transplantation. 30: 335-40. PMID 12235516 DOI: 10.1038/sj.bmt.1703649  0.284
2013 Armand P, Kim HT, Sainvil M, Bachanova V, Devine SM, Waller EK, Jagirdar N, Cutler CS, Ho VT, Koreth J, Alyea EP, McAfee SL, Chen Y, Soiffer RJ, Antin JH. The Addition Of Sirolimus To The Gvhd Prophylaxis Regimen In Reduced Intensity Allogeneic Stem Cell Transplantation For Lymphoma: A Multicenter Randomized Trial Blood. 122: 704-704. DOI: 10.1182/BLOOD.V122.21.704.704  0.282
2007 Waller E, Ninan MJ, Roback J, Arellano M, Flowers C. The occurrence of idiopathic secondary post-transplant thrombocytopenia and the kinetics of platelet recovery predict survival in patients undergoing autologous hematopoietic progenitor cell transplantation Journal of Clinical Oncology. 25: 7109-7109. DOI: 10.1200/jco.2007.25.18_suppl.7109  0.282
2016 Mann ML, Batllori E, Moritz MA, Waller EK, Berck P, Flint AL, Flint LE, Dolfi E. Incorporating Anthropogenic Influences into Fire Probability Models: Effects of Human Activity and Climate Change on Fire Activity in California. Plos One. 11: e0153589. PMID 27124597 DOI: 10.1371/Journal.Pone.0153589  0.282
2007 Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 844-52. PMID 17580263 DOI: 10.1016/J.Bbmt.2007.03.011  0.281
2013 Darlak KA, Wang Y, Li JM, Harris WA, Owens LM, Waller EK. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1331-9. PMID 23810844 DOI: 10.1016/j.bbmt.2013.06.016  0.281
2008 Darlak KA, Li J, Harris W, Waller EK. Selective Depletion of CD11b+ Dendritic Cells from Murine Allogeneic Bone Marrow Grafts Promotes a Th1 Phenotype in Donor T Cells Blood. 112: 4610-4610. DOI: 10.1182/blood.V112.11.4610.4610  0.281
2011 Kean LS, Langston A, Qayad M, Khoury HJ, Tiwari D, Couture C, Renfroe H, Sen S, Robertson J, Waller EK, Horan JT. CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GvHD During High-Risk Unrelated HSCT: A First-in-Disease Feasibility Trial, Blood. 118: 4078-4078. DOI: 10.1182/blood.V118.21.4078.4078  0.28
2016 Li JM, Petersen CT, Li J, Panjwani R, Chandra DJ, Giver CR, Blazar BR, Waller EK. Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Vasoactive Intestinal Peptide. Cancer Research. PMID 27671676 DOI: 10.1158/0008-5472.Can-16-0427  0.28
2012 Vaughn ML, Waller EK. Monitoring blood for CD34+ cells to determine timing of Hematopoietic Progenitor Cells Apheresis Methods in Molecular Biology (Clifton, N.J.). 904: 79-83. PMID 22890923 DOI: 10.1007/978-1-61779-943-3_6  0.28
2008 Arellano ML, Harris W, Langston A, McMillan S, Rosenthal H, Waller EK. Induction of GvL after allogeneic stem cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 18004. PMID 27950829 DOI: 10.1200/jco.2008.26.15_suppl.18004  0.28
2015 Krishnamurti L, Sullivan KM, Kamani NR, Waller EK, Abraham A, Campigotto F, Zhang W, Smith S, Hassell KL, Decastro L, Wu CJ, Neuberg DS, Walters MC. Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE) Blood. 126: 543-543. DOI: 10.1182/BLOOD.V126.23.543.543  0.279
2005 Hossain MS, Robak JD, Waller EK. Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation. Blood. 106: 3024-3024. DOI: 10.1182/blood.v106.11.3024.3024  0.278
2018 Poitras TB, Villarreal ML, Waller EK, Nauman TW, Miller ME, Duniway MC. Identifying optimal remotely-sensed variables for ecosystem monitoring in Colorado Plateau drylands Journal of Arid Environments. 153: 76-87. DOI: 10.1016/J.Jaridenv.2017.12.008  0.278
2012 Tiwari D, Horan J, Langston A, Qayed M, Carr J, Renfroe H, Cynthia C, Khoury HJ, Jennifer R, Harvey RD, Mehta A, Waller EK, Kean LS. A First-in-Disease Trial of in Vivo Costimulation Blockade for Acute GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD Blood. 120: 741-741. DOI: 10.1182/BLOOD.V120.21.741.741  0.277
2007 Ninan MJ, Flowers CR, Roback JD, Arellano ML, Waller EK. Posttransplant Thrombopoiesis Predicts Survival in Patients Undergoing Autologous Hematopoietic Progenitor Cell Transplantation Biology of Blood and Marrow Transplantation. 13: 895-904. PMID 17640593 DOI: 10.1016/j.bbmt.2007.04.001  0.276
2018 Li Y, Waller EK. Vasoactive Intestinal Peptide Synthesis in Transplant Recipients Critically Regulate Donor T Cell Alloreactivity and Graft-Versus-Host Disease Blood. 132: 480-480. DOI: 10.1182/blood-2018-99-116077  0.275
2009 Fan KT, Li J, Lu Y, Harris W, Darlak KA, Forghani P, Shin K, Huang C, Waller EK. Donor Dendritic Cells Home to Lymphoid Organs in Allogeneic Transplant Recipients, Enhance Donor T-Cell Chimerism, and Polarize Donor T-Cell Activation. Blood. 114: 62-62. DOI: 10.1182/BLOOD.V114.22.62.62  0.275
2018 Waller EK, Crimmins TM, Walker JJ, Posthumus EE, Weltzin JF. Differential changes in the onset of spring across US National Wildlife Refuges and North American migratory bird flyways. Plos One. 13: e0202495. PMID 30208065 DOI: 10.1371/Journal.Pone.0202495  0.275
2007 Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience Biology of Blood and Marrow Transplantation. 13: 116-123. PMID 17222760 DOI: 10.1016/j.bbmt.2006.09.005  0.275
2012 Lu Y, Giver CR, Sharma A, Li JM, Darlak KA, Owens LM, Roback JD, Galipeau J, Waller EK. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity Blood. 119: 1075-1085. PMID 22130799 DOI: 10.1182/blood-2010-12-322891  0.275
2008 Hossain MS, Roback JD, Wang F, Waller EK. Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection. Journal of Immunology (Baltimore, Md. : 1950). 180: 6892-902. PMID 18453610  0.275
2011 Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood. 117: 6963-70. PMID 21464372 DOI: 10.1182/blood-2011-01-332007  0.274
2009 Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK. Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy. 1: 599-621. PMID 20191089 DOI: 10.2217/imt.09.32  0.274
2001 Adams AB, Durham MM, Kean L, Shirasugi N, Ha J, Williams MA, Rees PA, Cheung MC, Mittelstaedt S, Bingaman AW, Archer DR, Pearson TC, Waller EK, Larsen CP. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. Journal of Immunology (Baltimore, Md. : 1950). 167: 1103-11. PMID 11441122 DOI: 10.4049/Jimmunol.167.2.1103  0.274
2012 Weisdorf D, Cooley S, Devine S, Fehniger TA, DiPersio J, Anasetti C, Waller EK, Porter D, Farag S, Drobyski W, Defor T, Haagenson M, Curtsinger J, Miller J. T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 937-43. PMID 22155505 DOI: 10.1016/J.Bbmt.2011.11.024  0.274
2015 Gul Z, Van Meter E, Abidi M, Ditah I, Abdul-Hussein M, Deol A, Ayash L, Lum LG, Waller EK, Ratanatharathorn V, Uberti J, Al-Kadhimi Z. Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort. Bone Marrow Transplantation. 50: 432-7. PMID 25599169 DOI: 10.1038/bmt.2014.284  0.273
2016 Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani B, Waller E, et al. Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Bone Marrow Transplantation. PMID 27042847 DOI: 10.1038/bmt.2016.89  0.273
2015 Li J, Petersen CT, Li J, Giver CR, Blazar BR, Waller EK. Blocking VIP Signaling during Allogeneic Bone Marrow Transplantation Separates the Graft Versus Leukemia from Graft Versus Host Disease Activity of Donor CD8 T-Cells Blood. 126: 1877-1877. DOI: 10.1182/Blood.V126.23.1877.1877  0.273
2003 Waller EK, Langston AA, Lonial S, Cherry J, Somani J, Allen AJ, Rosenthal H, Redei I. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biology of Blood and Marrow Transplantation. 9: 460-471. DOI: 10.1016/S1083-8791(03)00127-7  0.273
2019 Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, ... ... Waller EK, et al. The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30716454 DOI: 10.1016/J.Bbmt.2019.01.034  0.272
2008 Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, ... ... Waller EK, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 112: 426-34. PMID 18398065 DOI: 10.1182/Blood-2007-12-128918  0.272
2014 Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, ... ... Waller EK, et al. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 273-81. PMID 24344210 DOI: 10.1200/JCO.2013.49.2454  0.272
2012 Li J, Yun HD, Waller EK. Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD. Blood. 120: 3001-3001. DOI: 10.1182/blood.v120.21.3001.3001  0.272
2009 Hossain MS, Harris WA, Myers SW, Akhtari M, Langston AA, Waller EK. Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients. Blood. 114: 1165-1165. DOI: 10.1182/blood.V114.22.1165.1165  0.272
2014 Hosoba S, Waller EK, Barclay S, Easley KA, Shenvi N, Roback J, Zimring JC, Giver CR. Dose and Time-Dependent Association of Red Blood Cell Transfusion with Increased Risk of GvHD and Worse Survival after Allogeneic HSCT Blood. 124: 1555-1555. DOI: 10.1182/blood.v124.21.1555.1555  0.272
2012 Hamilton ES, Waller EK. Hematopoietic Progenitor Cell Apheresis processing Methods in Molecular Biology (Clifton, N.J.). 904: 97-109. PMID 22890926 DOI: 10.1007/978-1-61779-943-3_9  0.271
2001 Lonial S, Bomberger C, Waller EK. Changes in the pattern of TCR Vβ repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans British Journal of Haematology. 113: 224-230. PMID 11328305 DOI: 10.1046/j.1365-2141.2001.02697.x  0.27
1999 Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease Blood. 94: 3222-3233. PMID 10556211  0.27
2015 Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L, Garrett A, Chen J, Betz KM, Ziegler CG, Tharp GK, ... ... Waller EK, et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. Science Translational Medicine. 7: 315ra191. PMID 26606970 DOI: 10.1126/Scitranslmed.Aad3231  0.269
2004 Hossain MS, Roback JD, Waller EK. MCMV Infection Lowers the Threshold for the Development of Clinical GvHD after Allogeneic Bone Marrow Transplantation. Blood. 104: 2125-2125. DOI: 10.1182/blood.V104.11.2125.2125  0.269
2000 Langston A, Jones TW, Rosenthal H, Redei I, Lonial S, Waller EK. Chronic GVHD (cGVHD) after matched sibling BMT is predicted by the number of transplanted donor NK-like T cells Blood. 96.  0.268
2018 Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, et al. Peri-Transplant RBC Transfusion is Associated with Increased Risk of GvHD after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29307717 DOI: 10.1016/j.bbmt.2018.01.003  0.268
2011 Wang Y, Li J, Harris WA, Giver CR, Waller EK. Lack of Host Bone Marrow-Derived Interleukin-12 Increased the Incidence of Allograft Rejection in Allogeneic Bone Marrow Transplantation Blood. 118: 2960-2960. DOI: 10.1182/blood.v118.21.2960.2960  0.267
2019 Krishnamurti L, Neuberg DS, Sullivan KM, Kamani NR, Abraham A, Campigotto F, Zhang W, Dahdoul T, De Castro L, Parikh S, Bakshi N, Haight A, Hassell KL, Loving R, Rosenthal J, ... ... Waller EK, et al. Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study. American Journal of Hematology. PMID 30637784 DOI: 10.1002/ajh.25401  0.267
2016 Armand P, Kim HT, Sainvil MM, Lange PB, Giardino AA, Bachanova V, Devine SM, Waller EK, Jagirdar N, Herrera AF, Cutler C, Ho VT, Koreth J, Alyea EP, McAfee SL, et al. The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. British Journal of Haematology. PMID 26729448 DOI: 10.1111/bjh.13931  0.267
2008 Dejoubner N, Ali Z, Grasier M, Hamilton E, Flowers C, Lonial S, Langston A, Waller EK. The prognostic significance of donor dendritic cells in allogeneic hematopoietic progenitor cell transplant. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7044. PMID 27949603 DOI: 10.1200/jco.2008.26.15_suppl.7044  0.267
2011 Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, Marks DI, McCarthy PL, Oudshoorn M, Petersdorf EW, Ringdén O, Setterholm M, Spellman SR, Waller EK, Gajewski JL, et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 640-8. PMID 20674756 DOI: 10.1016/J.Bbmt.2010.07.022  0.266
2012 Kozyr N, Ramakrishnan S, Polnett A, Hamby K, Tiwari D, Deane T, Stempora L, Jenkins J, Strobert E, Garcia A, Sharma P, Courtney C, Panoskaltsis-Mortari A, Giver CR, Waller EK, et al. Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade. Blood. 120: 2998-2998. DOI: 10.1182/Blood.V120.21.2998.2998  0.266
2017 Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK. Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & Lymphoma. 1-7. PMID 28782395 DOI: 10.1080/10428194.2017.1361027  0.265
2007 Hossain MS, Roback JD, Pollack BP, Jaye DL, Langston A, Waller EK. Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood. 109: 4548-56. PMID 17289817 DOI: 10.1182/blood-2006-04-017442  0.265
2019 Chen YB, Le-Rademacher J, Brazauskas R, Kiefer DM, Hamadani M, DiPersio JF, Litzow MR, Craig M, Horwitz ME, Artz AS, McClune BL, Fernandez HF, Duong HK, Kobusingye H, Proue M, ... ... Waller EK, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 3: 875-883. PMID 30890544 DOI: 10.1182/bloodadvances.2018027599  0.265
2001 Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM. The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. Blood. 98: 3205-11. PMID 11719355 DOI: 10.1182/Blood.V98.12.3205  0.265
2018 Ulezko Antonova A, Wang Y, Hassan M, Li Y, Waller EK. CD31 Expression Defines Heterogeneity of Donor Plasmacytoid Dendritic Cell Populations That Home to the Thymus: Implications for Control of GvHD Blood. 132: 3325-3325. DOI: 10.1182/blood-2018-99-113047  0.265
2016 Furlan SN, Watkins B, Tkachev V, Cooley S, Panoskaltsis-Mortari A, Betz K, Brown M, Hunt DJ, Schell JB, Zeleski K, Yu A, Giver C, Waller E, Miller JS, Blazar BR, et al. Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and man. Blood. PMID 27758873 DOI: 10.1182/Blood-2016-07-726547  0.264
2015 Copland IB, Qayed M, Garcia MA, Galipeau J, Waller EK. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 934-40. PMID 25659882 DOI: 10.1016/j.bbmt.2015.01.014  0.264
1998 Bomberger C, Singh-Jairam M, Rodey G, Guerriero A, Yeager AM, Fleming WH, Holland HK, Waller EK. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood. 91: 2588-600. PMID 9516161  0.264
2016 Auletta JJ, Devine SM, Waller EK. Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden? Bone Marrow Transplantation. 51: 333-43. PMID 26642333 DOI: 10.1038/bmt.2015.301  0.264
2020 Zhou Z, Nath R, Cerny J, Wang HL, Zhang MJ, Abdel-Azim H, Agrawal V, Ahmed G, Al-Homsi AS, Aljurf M, Alkhateeb HB, Assal A, Bacher U, Bajel A, Bashir Q, ... ... Waller EK, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Advances. 4: 3180-3190. PMID 32663298 DOI: 10.1182/Bloodadvances.2019001266  0.264
1998 Zeder K, Waller EK, Redei I, Gerard Connaghan D, Fleming WH, Geller RB, Heffner LT, Hillyer CD, Holden J, Holland K, Jones W, Mccollum J, Mogul M, Phillips C, Rodey G, et al. Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation Cancer Research Therapy and Control. 5: 221-228.  0.264
2010 Hossain MS, Gewirtz AT, Roback J, Waller E. Paradoxical Immunological Activity of Flagellin: A Novel Method to Reduce GvHD In Allogeneic HSCT Recipients. Blood. 116: 1465-1465. DOI: 10.1182/Blood.V116.21.1465.1465  0.263
2014 Darlak KA, Wang Y, Li JM, Harris WA, Giver CR, Huang C, Waller EK. Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation. Journal of Hematology & Oncology. 7: 16. PMID 24580829 DOI: 10.1186/1756-8722-7-16  0.262
2012 Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. The New England Journal of Medicine. 367: 1487-96. PMID 23075175 DOI: 10.1056/Nejmoa1203517  0.262
2017 Al-Kadhimi Z, Gul Z, Abidi M, Lum LG, Deol A, Chen W, Jang H, Ozust C, Langston A, Waller E, Uberti J. Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention. Bone Marrow Transplantation. PMID 28581472 DOI: 10.1038/bmt.2017.95  0.262
2011 Prichard JM, Muppidi S, Flowers CR, Kaufman JL, Lechowicz MJ, Lonial S, Nooka AK, Sinha R, Waller EK, Langston A. Equivalent Survival Following Fludarabine/Melphalan Reduced Intensity Conditioning with or without Rabbit ATG As Part of GvHD Prophylaxis Blood. 118: 1959-1959. DOI: 10.1182/blood.V118.21.1959.1959  0.26
2001 Waller EK, Rosenthal H, Jones TW, Peel J, Lonial S, Langston A, Redei I, Jurickova I, Boyer MW. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood. 97: 2948-56. PMID 11342416 DOI: 10.1182/Blood.V97.10.2948  0.26
2014 Langston AA, Prichard JM, Muppidi S, Nooka A, Lechowicz MJ, Lonial S, Sinha R, Graiser M, Kaufman JL, Khoury HJ, Flowers CR, Waller EK. Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone Marrow Transplantation. 49: 185-9. PMID 24162613 DOI: 10.1038/bmt.2013.168  0.259
2007 Li JM, Waller EK. The yin and yang of adaptive immunity in allogeneic hematopoietic cell transplantation: donor antigen-presenting cells can either augment or inhibit donor T cell alloreactivity Advances in Experimental Medicine and Biology. 590: 69-87. PMID 17191378 DOI: 10.1007/978-0-387-34814-8_5  0.259
2015 Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, ... ... Waller EK, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 266-74. PMID 25445023 DOI: 10.1016/J.Bbmt.2014.10.021  0.259
2012 Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Anasetti C, Weisdorf D, Miller JS. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. Journal of Immunology (Baltimore, Md. : 1950). 189: 5082-8. PMID 23077239 DOI: 10.4049/Jimmunol.1201964  0.258
2008 Lu Y, Li J, Harris W, Waller E. Paradoxical Effects of Interferon-γ in Allogeneic Bone Marrow Transplant: Donor Dendritic Cells Regulate Graft-Versus-Leukemia and Graft- Versus-Host Disease Activities. Blood. 112: 2343-2343. DOI: 10.1182/blood.V112.11.2343.2343  0.258
2014 Al-Kadhimi Z, Gul Z, Chen W, Smith D, Abidi M, Deol A, Ayash L, Lum L, Waller EK, Ratanatharathorn V, Uberti J. High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 979-85. PMID 24709007 DOI: 10.1016/j.bbmt.2014.03.016  0.258
2006 Brinker BT, Waller EK, Leong T, Heffner LT, Redei I, Langston AA, Lonial S. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer. 106: 2171-80. PMID 16598756 DOI: 10.1002/Cncr.21852  0.258
2013 Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, et al. Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 741-5. PMID 23380341 DOI: 10.1016/J.Bbmt.2013.01.020  0.258
2004 Lonial S, Torre C, Hicks M, Mcmillan S, Langston AA, Flowers CR, Lechowicz MJ, Waller EK. A Randomized Trial to Evaluate the Impact of Cytokines on Dendritic Cell, T-Cell and T-Cell Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant: An Interim Analysis. Blood. 104: 2854-2854. DOI: 10.1182/blood.v104.11.2854.2854  0.258
2013 Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, ... ... Waller EK, et al. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1102-8. PMID 23632091 DOI: 10.1016/J.Bbmt.2013.04.022  0.257
2013 Flowers CR, Lill M, Costa LJ, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Reddy V, Braunschweig I, ... ... Waller EK, et al. Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America Blood. 122: 768-768. DOI: 10.1182/Blood.V122.21.768.768  0.257
2009 Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, Bevan MJ, Waller EK, Yu XZ, Beg AA. PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. The Journal of Clinical Investigation. 119: 3774-86. PMID 19907075 DOI: 10.1172/Jci39692  0.256
2019 Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Maijhail N, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. PMID 31558669 DOI: 10.3324/Haematol.2019.220756  0.256
2011 Li J, Wang Y, Darlak K, Southerland LT, Hossain MS, Giver CR, Waschek JA, Waller EK. Blocking Vasoactive Intestinal Peptide Signaling Enhances Anti-Viral Immunity without Increased Graft Versus Host Disease in Murine Allogeneic Bone Marrow Transplantation Blood. 118: 1002-1002. DOI: 10.1182/Blood.V118.21.1002.1002  0.256
2014 Hosoba S, Harris WA, Lin KL, Waller EK. Chemokine and lymph node homing receptor expression on pDC vary by graft source. Oncoimmunology. 3: e958957. PMID 25941585 DOI: 10.4161/21624011.2014.958957  0.255
2003 Zhu Z, Waller E. Global Forest Cover Mapping for the United Nations Food and Agriculture Organization Forest Resources Assessment 2000 Program Forest Science. 49: 369-380. DOI: 10.1093/Forestscience/49.3.369  0.255
2020 Weisdorf D, Cooley S, Wang T, Trachtenberg E, Vierra-Green C, Spellman S, Sees JA, Spahn A, Vogel J, Fehniger TA, Woolfrey AE, Devine SM, Ross M, Waller EK, Sobecks RM, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Advances. 4: 740-754. PMID 32092137 DOI: 10.1182/Bloodadvances.2019001053  0.255
2014 Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A, Steuer C, Graiser M, Ali Z, Shah NN, Rangaraju S, Nickleach D, Gao J, Lonial S, Waller EK. Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 852-7. PMID 24607557 DOI: 10.1016/J.Bbmt.2014.02.025  0.254
1997 Geller RB, Devine SM, O'Toole K, Persons L, Keller J, Mauer D, Holland HK, Dix SP, Piotti M, Redei I, Connaghan G, Heffner LT, Hillyer CD, Waller EK, Winton EF, et al. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation Bone Marrow Transplantation. 20: 219-225. PMID 9257890  0.254
2013 Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 460-7. PMID 23201472 DOI: 10.1016/j.bbmt.2012.11.017  0.253
2011 Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Weisdorf DJ, Miller JS. NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. Blood. 118: 2784-92. PMID 21757615 DOI: 10.1182/Blood-2011-04-347070  0.253
2013 Harvey RD, Kaufman JL, Johnson HR, Nooka A, Vaughn L, Flowers CR, Khoury HJ, Lechowicz MJ, Langston AA, Lonial S, Waller EK. Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1393-5. PMID 23764455 DOI: 10.1016/j.bbmt.2013.06.003  0.253
2019 Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, ... ... Waller EK, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 3: 1826-1836. PMID 31201170 DOI: 10.1182/Bloodadvances.2019000050  0.253
2018 Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK. Safety and survival outcomes for bloodless transplantation in patients with myeloma. Cancer. PMID 30480777 DOI: 10.1002/Cncr.31677  0.253
2019 Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, ... ... Waller EK, et al. Impact of T-cell dose on the outcome of T-cell replete HLA matched allogeneic peripheral blood stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31085303 DOI: 10.1016/J.Bbmt.2019.05.007  0.252
1997 Redei I, Waller EK, Holland HK, Devine SM, Wingard JR. Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions Bone Marrow Transplantation. 19: 175-177. PMID 9116616  0.251
2019 Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, ... ... Waller EK, et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood Advances. 3: 2836-2844. PMID 31582392 DOI: 10.1182/bloodadvances.2019000627  0.251
2000 Waller EK, Längsten AA, Bucur S, Lonial S, Cherry J, Feinstein B, Redei I. Sequential CD34+ and CD3+ allogeneic cell transplants in patients with poor risk hematologic malignancies Blood. 96.  0.25
2007 Southerland LT, Li J, Hossain S, Giver C, Harris W, Waschek J, Waller EK. The Absence of Vasoactive Intestinal Peptide Augments Allo-Reactivity and the Anti-Viral Response in Bone Marrow Transplantation. Blood. 110: 3267-3267. DOI: 10.1182/Blood.V110.11.3267.3267  0.25
2017 Qayed M, Arafat D, Banskota S, Horan J, Waller E, Gibson G. 2136 Journal of Clinical and Translational Science. 1: 57-57. DOI: 10.1017/cts.2017.204  0.25
2014 Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Langston A, Pentz R, Waller EK. Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation Blood. 124: 6002-6002. DOI: 10.1182/Blood.V124.21.6002.6002  0.249
2014 Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, et al. Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 202-8. PMID 24184335 DOI: 10.1016/j.bbmt.2013.10.023  0.249
2012 Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, et al. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 280-8. PMID 21810400 DOI: 10.1016/J.Bbmt.2011.07.024  0.248
2011 Desmarets M, Mylvaganam G, Waller EK, Josephson CD, Pack C, Lukacher AE, Zimring JC. Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function American Journal of Transplantation. 11: 1825-1834. PMID 21884408 DOI: 10.1111/J.1600-6143.2011.03730.X  0.248
1999 Lonial S, Bilodeau PA, Langston AA, Lewis C, Mossavi-Sai S, Holden JT, Waller EK. Acquired amegakaryocytic thrombocytopenia treated with allogeneic: BMT: A case report and review of the literature Bone Marrow Transplantation. 24: 1337-1341. PMID 10627644  0.248
2005 Arellano ML, Langston A, Lonial S, Flowers C, Khoury JH, Winton E, Waller EK, Mary LJ. Decreased Incidence of Relapse in Patients with Acute Leukemia Transplanted from Matched Unrelated Donors: Induction of GvL. Blood. 106: 2016-2016. DOI: 10.1182/blood.v106.11.2016.2016  0.246
2006 Ninan M, Arellano M, Philip A, Langston A, Flowers C, Lonial S, Kaufman J, Lechowicz M, Khoury J, Roback J, Waller E. Idiopathic secondary post-transplant thrombocytopenia (ISPT) following autologous hematopoietic progenitor cell transplantation (HPCT) is associated with transplantation of lower numbers of primitive hematopoietic progenitors Biology of Blood and Marrow Transplantation. 12: 132. DOI: 10.1016/j.bbmt.2005.11.407  0.244
2015 Li J, Panjwani R, Li J, Giver CR, Malone M, Waller EK. T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy Blood. 126: 3438-3438. DOI: 10.1182/blood.V126.23.3438.3438  0.243
2018 Ip A, Switchenko JM, Graiser M, Koff J, Gupta V, Lechowicz M, Al-Kadhimi Z, Nooka A, Kaufman J, Lonial S, Waller EK, Langston AA, Flowers C, Cohen JB. Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT) Biology of Blood and Marrow Transplantation. 24: S137-S138. DOI: 10.1016/J.Bbmt.2017.12.085  0.243
2014 Hossain MS, Kunter GM, Najjar VF, Jaye DL, Waller EK. Upregulation of Immune Checkpoint Blockade Molecules Post Allogeneic Stem Cell Transplantation Is Necessary but Insufficient to Prevent GvHD Blood. 124: 1101-1101. DOI: 10.1182/blood.V124.21.1101.1101  0.243
2004 Waller EK. Cellular Immunotherapy and Cancer Seminars in Oncology. 31: 87-90. PMID 15124140  0.241
2007 Southerland L, Li J, Waller E. 37: The allo-reactivity of donor T-cells is shaped by the presence of immunostimulatory or immunosuppressive donor dendritic cell subsets in the graft Biology of Blood and Marrow Transplantation. 13: 16. DOI: 10.1016/j.bbmt.2006.12.040  0.241
2018 McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, ... Waller EK, et al. Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. Blood Advances. 2: 299-307. PMID 29440002 DOI: 10.1182/bloodadvances.2017014829  0.241
2018 Ip A, Switchenko JM, Graiser M, Koff JL, Gupta VA, Lechowicz MJ, Nooka AK, Kaufman JL, Lonial S, Waller EK, Langston AA, Al-Kadhimi ZS, Kota V, Blum WG, Klisovic RB, et al. Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL). Journal of Clinical Oncology. 36: e19509-e19509. DOI: 10.1200/Jco.2018.36.15_Suppl.E19509  0.241
2016 Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, ... ... Waller EK, et al. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269951 DOI: 10.1200/JCO.2015.66.3476  0.241
2019 Rashidi A, Luo X, Cooley S, Anasetti C, Waller EK, Brunstein CG, Cichocki F, Weisdorf DJ, Miller JS. The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples. Blood Advances. 3: 2465-2469. PMID 31427278 DOI: 10.1182/Bloodadvances.2019000298  0.24
2020 Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, ... ... Waller E, et al. Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32649981 DOI: 10.1016/j.bbmt.2020.06.029  0.24
2011 Li J, Deppa JA, Ali Z, Graiser M, Langston A, Gleason C, Thomas J, Waller EK. Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Blood. 118: 2049-2049. DOI: 10.1182/blood.v118.21.2049.2049  0.239
2013 Li JM, Hossain MS, Southerland L, Waller EK. Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients. Blood. 121: 2347-51. PMID 23325838 DOI: 10.1182/blood-2012-06-437640  0.238
2013 Kaufman JL, Flowers CR, Rados KD, Calandra GB, Vose JM, Hewes LB, Lonial S, Langston AA, Khoury HJ, Lechowicz MJ, Waller EK. A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion. 53: 76-84. PMID 22624594 DOI: 10.1111/j.1537-2995.2012.03719.x  0.238
2006 Rosenthal H, Somani J, Nolte F, Waller E. Antigen specific T-cell response to Aspergillus fumigatus in unrelated allogeneic transplant recipients Biology of Blood and Marrow Transplantation. 12: 41-42. DOI: 10.1016/j.bbmt.2005.11.130  0.237
2005 Smith MM, Giver CR, Waller EK, Flowers CR. Ex Vivo Fludarabine Selectively Depletes Human Naive T-Cell Subsets: A Step Toward Modifying Donor Lymphocyte Infusion. Blood. 106: 1071-1071. DOI: 10.1182/blood.v106.11.1071.1071  0.237
2002 Langston AA, Redei I, Caliendo AM, Somani J, Hutcherson D, Lonial S, Bucur S, Cherry J, Allen A, Waller EK. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood. 99: 1085-8. PMID 11807018 DOI: 10.1182/blood.V99.3.1085  0.237
2000 Sonnier SA, Waller EK. Increased risk of thrombotic microangiopathy associated with high levels of tacrolimus in the post-transplant period Blood. 96.  0.237
2016 DeFilipp Z, Rosand CB, Goldstein DA, Master VA, Carthon BC, Harris WB, Kucuk O, Al-Kadhimi Z, Cohen JB, Flowers CR, Lechowicz MJ, Nooka AK, Kaufman JL, Langston AA, Chen Z, ... ... Waller EK, et al. Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone Marrow Transplantation. PMID 27427922 DOI: 10.1038/Bmt.2016.189  0.236
2015 Hosoba S, Jaye DL, Cohen C, Roback JD, Waller EK. Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature. Transfusion. 55: 259-64. PMID 25156334 DOI: 10.1111/trf.12815  0.235
2012 Cutler C, Logan BR, Nakamura R, Johnston L, Choi SW, Porter DL, Hogan WJ, Pasquini MC, MacMillan ML, Wingard JR, Waller EK, Grupp SA, McCarthy PL, Wu J, Hu Z, et al. Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402 Blood. 120: 739-739. DOI: 10.1182/Blood.V120.21.739.739  0.235
2012 DeJoubner NJ, Li Q, Harris WA, Wang Z, Liu Y, Waller EK. Advanced Non Small Cell Lung Cancer Patients with Fewer Numbers of Blood Myeloid Dendritic Cells and CD4 Cells Prior to Treatment Have Inferior Progression-Free Survival: Implications for Cancer Immunotherapy Blood. 120: 4837-4837. DOI: 10.1182/blood.v120.21.4837.4837  0.235
2012 Bacher U, Klyuchnikov E, Le-Rademacher J, Carreras J, Armand P, Bishop MR, Bredeson CN, Cairo MS, Fenske TS, Freytes CO, Gale RP, Gibson J, Isola LM, Inwards DJ, Laport GG, ... ... Waller EK, et al. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Blood. 120: 4256-62. PMID 23007405 DOI: 10.1182/blood-2012-06-436725  0.235
2000 Roback JD, Mittelstaedt S, Hillyer CD, Waller EK. Adoptive immunotherapy with fludarabine-treated cytomegalovirus primed donor splenocytes following mhc mis-matched allogeneic bone marrow transplantation in mice Blood. 96.  0.234
2007 Waller EK. Hemorrhagic cystitis after hematopoietic stem cell transplantation: Much progress and many remaining issues Chinese Medical Journal. 120: 1671. PMID 17935667  0.234
2013 Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, et al. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1615-24. PMID 23939198 DOI: 10.1016/j.bbmt.2013.08.002  0.234
2008 Vose JM, Young A, Friedberg JW, Waller EK, Cheson BD, Trommeshauser D, Munzert G. Phase I Dose-Escalation Trial of BI 2536, a Polo-Like Kinase 1 Inhibitor, in Relapsed and Refractory Non-Hodgkin’s Lymphoma Blood. 112: 233-233. DOI: 10.1182/BLOOD.V112.11.233.233  0.233
2007 Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion. 47: 629-35. PMID 17381621 DOI: 10.1111/j.1537-2995.2007.01164.x  0.233
2014 Furlan SN, Watkins B, Flynn RP, Ramakrishnan S, Singh K, Giver CR, Hanby K, Stempora L, Garrett AP, Ziegler CG, Tharp G, Bosinger S, Blazar BR, Waller EK, Kean LS. Defining the Primate T Cell Transcriptome during Graft Versus Host Disease: New Data Implicating the Hedgehog and Aurora Kinase Pathways in Pathogenesis and Prevention Blood. 124: 2432-2432. DOI: 10.1182/Blood.V124.21.2432.2432  0.231
2017 Hossain MS, Kunter GM, El-Najjar VF, Jaye DL, Al-Kadhimi Z, Taofeek OK, Li JM, Waller EK. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients. Plos One. 12: e0184254. PMID 28953925 DOI: 10.1371/journal.pone.0184254  0.231
2014 Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International Journal of Radiation Oncology, Biology, Physics. 89: 360-9. PMID 24837891 DOI: 10.1016/J.Ijrobp.2014.02.032  0.231
2005 SHI H, SINGH A, KANT S, ZHU Z, WALLER E. Integrating Habitat Status, Human Population Pressure, and Protection Status into Biodiversity Conservation Priority Setting Conservation Biology. 19: 1273-1285. DOI: 10.1111/J.1523-1739.2005.00225.X  0.231
2008 Murali S, Winton E, Waller EK, Heffner LT, Lonial S, Flowers C, Kaufman J, Arellano M, Lechowicz MJ, Mann KP, Khoury HJ, Langston AA. Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone Marrow Transplantation. 42: 529-34. PMID 18622414 DOI: 10.1038/bmt.2008.201  0.23
2014 Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, et al. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 89-97. PMID 24161923 DOI: 10.1016/j.bbmt.2013.10.018  0.23
2014 Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, ... ... Waller EK, et al. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 951-9. PMID 24641828 DOI: 10.1016/j.bbmt.2014.03.014  0.23
2015 Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, Stempora L, Horan JT, Langston A, Qayed M, Khoury HJ, Grizzle A, Cheeseman JA, Conger JA, Robertson J, ... ... Waller EK, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 125: 3835-50. PMID 25852054 DOI: 10.1182/Blood-2015-03-631853  0.229
2004 Arellano M, Waller EK. GM-CSF + INF-alpha induce a graft-versus-leukemia effect in BMT patients with relapsed AML and ALL. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 6634. PMID 28016350 DOI: 10.1200/jco.2004.22.14_suppl.6634  0.228
2016 Edelman S, Waller EK, Graiser M, Langston AA, Dhere V, Mikell JL, Switchenko JM, Esiashvili N, Khan MK. Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia. International Journal of Radiation Oncology, Biology, Physics. 96: E493-E494. PMID 27674838 DOI: 10.1016/J.Ijrobp.2016.06.1867  0.228
2011 Sharma A, Duan M, Graiser M, Zhang H, Langston A, Lonial S, Flowers CR, Haight A, Waller EK. Older Patients with Hodgkin Lymphoma (HL) Undergoing Autologous Stem Cell Transplantation for Relapsed/Refractory Disease Have Inferior Survival Compared to Younger Patients Blood. 118: 4521-4521. DOI: 10.1182/blood.v118.21.4521.4521  0.228
2018 Gandelman JS, Song DJ, Chen H, Engelhardt BG, Chen YB, Clark WB, Giver CR, Waller EK, Jung DK, Jagasia M. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29981848 DOI: 10.1016/j.bbmt.2018.06.035  0.228
2016 Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, ... ... Waller EK, et al. Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27040394 DOI: 10.1016/J.Bbmt.2016.03.018  0.227
2010 Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Kaufman JL, Lonial S, Flowers CR, Lechowicz MJ, Langston A, Anderson D, Waller E. Cost-Effectiveness Analysis of a “Just-In-Time” Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant Blood. 116: 2246-2246. DOI: 10.1182/BLOOD.V116.21.2246.2246  0.226
2013 Nooka AK, Langston AA, Waller EK, Heffner LT, Gleason C, Muppidi S, Watson M, Casbourne D, Boise L, Kaufman JL, Lonial S. Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM). Journal of Clinical Oncology. 31: 8540-8540. DOI: 10.1200/Jco.2013.31.15_Suppl.8540  0.224
2018 Swimm A, Giver CR, DeFilipp Z, Rangaraju S, Sharma A, Ulezko Antonova A, Sonowal R, Capaldo C, Powell D, Qayed M, Kalman D, Waller EK. Indoles derived from intestinal microbiota act via type I interferon signaling to limit Graft-versus-Host-Disease. Blood. PMID 30257880 DOI: 10.1182/Blood-2018-03-838193  0.224
2011 Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, ... ... Waller EK, et al. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1018-24. PMID 21034842 DOI: 10.1016/j.bbmt.2010.10.029  0.224
2016 DeFilipp Z, Rosand CB, Goldstein DA, Master VA, Carthon BC, Harris WB, Kucuk O, Waller EK. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Previously Treated Germ Cell Tumors: A Single-Center Experience Biology of Blood and Marrow Transplantation. 22: S421-S422. DOI: 10.1016/j.bbmt.2015.11.963  0.224
2014 Shah N, Nooka AK, Lonial S, Khoury HJ, Waller E, Langston A. Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents Online Journal of Public Health Informatics. 6. DOI: 10.5210/ojphi.v6i1.5143  0.224
2013 Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 121: 197-206. PMID 23109243 DOI: 10.1182/Blood-2012-03-417667  0.223
2012 Nastoupil L, Shenoy PJ, Ambinder A, Seward M, Nooka AK, Waller EK, Langston A, Kaufman JL, King N, Lechowicz MJ, Lonial S, Sinha R, Flowers CR. Consolidation with High Dose Therapy and Autologous Stem Cell Transplant Improves Survival for Patients with Mantle Cell Lymphoma Blood. 120: 2006-2006. DOI: 10.1182/blood.v120.21.2006.2006  0.223
2018 Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, ... ... Waller EK, et al. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica. PMID 30381298 DOI: 10.3324/Haematol.2018.200121  0.223
2009 Hossain MS, Gewirtz AT, Roback JD, Waller EK. Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD. Blood. 114: 3561-3561. DOI: 10.1182/Blood.V114.22.3561.3561  0.222
2000 Amelia Längsten I, Redei, Bucur S, Cherry J, Alien A, Thourani J, Teagarden D, Mossavi-Sai S, Hutcherson D, Waller EK. Acyclovir (acv)-resistant herpes simplex virus (hsv) after t- and b-cell depleted haploidentical stem cell transplantation (sct) Blood. 96.  0.222
2018 Sanyi A, Jaye DL, Rosand CB, Box A, Shanmuganathan C, Waller EK. Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development. Biomarker Research. 6: 13. PMID 29588856 DOI: 10.1186/s40364-018-0127-x  0.222
2015 Nastoupil LJ, Shenoy PJ, Ambinder A, Koff JL, Nooka AK, Waller EK, Langston A, Seward M, Kaufman JL, Bernal-Mizrachi L, King N, Lechowicz MJ, Lonial S, Sinha R, Flowers CR. Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & Lymphoma. 56: 383-9. PMID 24828864 DOI: 10.3109/10428194.2014.921296  0.222
2018 Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, ... ... Waller EK, et al. Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Advances. 2: 933-940. PMID 29685953 DOI: 10.1182/bloodadvances.2018018531  0.222
2015 Stelton C, Geller R, Waller E, Langston A, Gebel H, Jaye D. 79: Improving Test Utilization for Chimerism Analysis After Hematopoietic Stem Cell Transplantation American Journal of Clinical Pathology. 143: A048-A048. DOI: 10.1093/ajcp/143.suppl1.049  0.222
2002 Shaw RN, Waller EK, Offermann MK. Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell line. Leukemia & Lymphoma. 43: 631-4. PMID 12002770 DOI: 10.1080/10428190290012173  0.222
2013 Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, et al. Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood. 121: 2567-73. PMID 23361908 DOI: 10.1182/blood-2012-08-453860  0.221
2018 Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman S, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, et al. KIR Donor Selection: Feasibility in Identifying Better Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30149149 DOI: 10.1016/J.Bbmt.2018.08.022  0.22
2010 Hossain M, Gewirtz A, Roback J, Waller E. Flagellin-TLR5 Immune Response: A Novel Mechanism To Reduce GvHD In Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 16: S160. DOI: 10.1016/J.Bbmt.2009.12.027  0.22
2018 Waller EK, Crimmins TM, Walker JJ, Posthumus EE, Weltzin JF. Correction: Differential changes in the onset of spring across US National Wildlife Refuges and North American migratory bird flyways. Plos One. 13: e0208348. PMID 30475903 DOI: 10.1371/Journal.Pone.0208348  0.219
1997 Waller EK, Worford LJ, Lynn M, Winton EF, Bray RA, Jones W, Rosenthal H, McCollum J, Holland HK, Yeager AM. Platelet recovery following autologous bone marrow transplantation correlates with the content of cd34+, cd38- cells in the marrow graft Experimental Hematology. 25: 898.  0.219
2018 Petersen CT, Hassan M, Morris AB, Jeffery J, Lee K, Jagirdar N, Staton AD, Raikar SS, Spencer HT, Sulchek T, Flowers CR, Waller EK. Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists. Blood Advances. 2: 210-223. PMID 29386194 DOI: 10.1182/Bloodadvances.2017011254  0.219
2017 Deng J, Li Y, Pennati A, Yuan S, Wu JH, Waller EK, Galipeau J. GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 25: 416-426. PMID 28153092 DOI: 10.1016/j.ymthe.2016.11.013  0.219
1998 Lopez RD, Poloso N, Negrin RS, Xu S, Waller EK. Engagement of CD2/LFA-2 on activated human peripheral blood T cells results in an IL-12-dependent resistance to Activation-Induced Cell Death (AICD) in γδ T cells Faseb Journal. 12.  0.218
2010 Forghani P, Harris W, Li j, Khorramizadeh M, Waller E. CD11b+gr-1+ myeloid Derived Suppressor Cells (MDSC) In Normal Bone Marrow Suppress T Cell Proliferation and Enhance T-Regulatory Function Via a IL10-, IL4- and IDO-Independent Mechanism Blood. 116: 4801-4801. DOI: 10.1182/BLOOD.V116.21.4801.4801  0.217
2013 Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, ... ... Waller EK, et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 122: 3863-70. PMID 24065243 DOI: 10.1182/Blood-2013-07-514448  0.217
2017 Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljuf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, ... ... Waller EK, et al. Influence of Age on Acute and Chronic GVHD in Children Receiving HLA-Identical Sibling BMT for Acute Leukemia: Implications for Prophylaxis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29155316 DOI: 10.1016/J.Bbmt.2017.11.004  0.217
2012 Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Pharmacokinetic-Directed High-Dose Busulfan Combined with Cyclophosphamide and Etoposide Results in Predictable Drug Levels and Durable Long-Term Survival in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 18: 1287-1294. PMID 22370160 DOI: 10.1016/j.bbmt.2012.02.006  0.216
2015 Hossain MS, Al-Kadhimi Z, Waller EK. TLR5 Agonist Recombinant Flagellin, CBLB502 Increases Anti-CMV Immunity By Increasing T-Bet and Eomes Expressing T Cells after MCMV Infection Blood. 126: 3082-3082. DOI: 10.1182/blood.V126.23.3082.3082  0.216
2014 Kaliyaperumal S, Watkins B, Sharma P, Furlan S, Ramakrishnan S, Giver C, Garcia A, Courtney C, Knight H, Strobert E, Elder E, Crenshaw T, Blazar BR, Waller EK, Westmoreland S, et al. CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis. Blood. 123: 1967-9. PMID 24652969 DOI: 10.1182/Blood-2014-01-547612  0.216
2007 Pecora AL, Preti RA, Chan WS, Waller EK, Quyyumi A, Vaughan D, Moss T. Bone Marrow Derived CD34+CXCR4+ Cells Maintain Viability, Mobility and Sterility up to 72 Hours and Are Compatible with Balloon Dilatation Catheters Used for Intra Coronary Artery Infusion; Pre-Clinical Development of a Pharmaceutical Grade Cell Therapy for Acute Myocardial Infarction (AMR-001). Blood. 110: 1214-1214. DOI: 10.1182/Blood.V110.11.1214.1214  0.216
2010 McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, Dipersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, ... ... Waller EK, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1878-87. PMID 20212255 DOI: 10.1200/Jco.2009.25.4821  0.216
2014 Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood. 124: 1372-7. PMID 24982504 DOI: 10.1182/Blood-2014-04-567164  0.215
2019 Villarreal ML, Soulard CE, Waller EK. Landsat time series assessment of invasive annual grasses following energy development Remote Sensing. 11: 2553. DOI: 10.3390/Rs11212553  0.215
2009 Renfroe H, Waller EK, Arnold M, Vaughn L, Harvey RD, Hamilton E, Lonial S, Khoury HJ, Kaufman JL, Lechowicz MJ. A Randomized Clinical Trial Comparing Cytokine Administration Sites for Mobilization of Peripheral Hematopoietic Progenitor Cells for Patients with Hematological Malignancies Undergoing Autologous Stem Cell Transplantation. Blood. 114: 4230-4230. DOI: 10.1182/blood.v114.22.4230.4230  0.215
2004 Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products Biology of Blood and Marrow Transplantation. 10: 848-957. PMID 15570253 DOI: 10.1016/j.bbmt.2004.07.008  0.215
2020 Awasthi R, Pacaud L, Waldron E, Tam CS, Jäger U, Borchmann P, Jaglowski S, Foley SR, van Besien K, Wagner-Johnston ND, Kersten MJ, Schuster SJ, Salles G, Maziarz RT, Anak Ö, ... ... Waller EK, et al. Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL. Blood Advances. 4: 560-572. PMID 32045475 DOI: 10.1182/bloodadvances.2019000525  0.215
2007 Santos EC, Sessions J, Hutcherson D, Flowers C, Langston A, Waller EK. Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation-A Similar Experience Biology of Blood and Marrow Transplantation. 13: 746-747. PMID 17531785 DOI: 10.1016/j.bbmt.2007.02.006  0.215
2010 Akhtari M, Giver CR, Ali Z, Flowers CR, Gleason CL, Hillyer CD, Kaufman J, Khoury HJ, Langston AA, Lechowicz MJ, Lonial S, Renfroe HM, Roback JD, Tighiouart M, Vaughn L, ... Waller EK, et al. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion. 50: 2424-31. PMID 20529004 DOI: 10.1111/j.1537-2995.2010.02712.x  0.214
2009 Lu Y, Waller EK. Dichotomous role of interferon-γ in allogeneic bone marrow transplant Biology of Blood and Marrow Transplantation. 15: 1347-1353. PMID 19822293 DOI: 10.1016/j.bbmt.2009.07.015  0.214
2015 Lee JH, Giver CR, Rangaraju S, Waller EK. Lateral Gene Transfer Contributing to Leukemogenesis Blood. 126: 1235-1235. DOI: 10.1182/blood.v126.23.1235.1235  0.213
2003 Rosenthal H, Miller J, Hicks M, Weisdorf D, Waller E. 176Time-temperature study of cell survival in Bone Marrow (BM) and Blood hematopoietic Progenitor Cell (HPC) grafts Biology of Blood and Marrow Transplantation. 9: 117-118. DOI: 10.1016/S1083-8791(03)80174-X  0.212
2010 Akhtari M, Hossain S, Forghani P, Waller E. Oral Human Recombinant Lactoferrin Prevents Acute Graft-Versus-Host Disease And Stimulates Reconstitution Of Donor Bone Marrow-Derived T-Cells In A Mouse Model Of Bone Marrow Transplantation Biology of Blood and Marrow Transplantation. 16: S305. DOI: 10.1016/J.BBMT.2009.12.446  0.211
2017 Petersen CT, Jagirdar N, Waller EK. Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy. Journal of Clinical Oncology. 35: e19017-e19017. DOI: 10.1200/jco.2017.35.15_suppl.e19017  0.211
2010 Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, ... Waller EK, et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 116: 1839-48. PMID 20538804 DOI: 10.1182/Blood-2010-04-278317  0.21
2018 Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ. Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. British Journal of Haematology. PMID 30004111 DOI: 10.1111/Bjh.15492  0.21
2019 Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, ... ... Waller EK, et al. Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31158502 DOI: 10.1016/J.Bbmt.2019.05.019  0.21
2011 Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, Langston A, Prichard JM, Anderson D, Gleason C, Lonial S, Flowers CR, Kaufman JL, Waller EK. Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion. 51: 2175-82. PMID 21492180 DOI: 10.1111/j.1537-2995.2011.03136.x  0.21
1992 Wilder RB, McGann JK, Sutherland WR, Waller EK, Minchinton AI, Goris ML, Moses LE, Knox SJ. The hypoxic cytotoxin sr 4233 enhances the antitumor activity of radioimmunotherapy in scid mice bearing transplanted human t cell lymphomas (ASTRO research fellowship) International Journal of Radiation Oncology*Biology*Physics. 24: 181-182. DOI: 10.1016/0360-3016(92)90231-6  0.209
2015 Suessmuth Y, Koura D, Finstermeier K, Desmarais C, Horan J, Langston A, Qayed M, Khoury HJ, Watkins BK, Robins H, Mukherjee R, Blazar BR, Waller EK, Mehta A, Kean LS. Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire Biology of Blood and Marrow Transplantation. 21: S69-S70. DOI: 10.1016/J.Bbmt.2014.11.074  0.209
2013 Summerbell ER, Giver CR, Rangaraju S, Darlak KA, Waller EK. Blocking VIP Signaling Abrogates Upregulation Of PD1 and Increases Proliferation Of Allo-Reactive T-Cells In a Mixed Lymphocyte Reaction Blood. 122: 1041-1041. DOI: 10.1182/blood.V122.21.1041.1041  0.209
2014 Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, ... ... Waller EK, et al. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia. 28: 658-65. PMID 23989431 DOI: 10.1038/Leu.2013.253  0.208
2012 Sharma A, Duan M, Chowdhury R, Graiser M, Zhang H, Langston A, Lonial S, Flowers C, Haight A, Waller E. BI-Modal Age Distribution of Patients with Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation Correlates with Markedly Inferior Survival Among Patients Age 35 Years and Older Biology of Blood and Marrow Transplantation. 18: S296. DOI: 10.1016/j.bbmt.2011.12.236  0.208
2009 Akhtari M, Giver C, Renfroe H, Langston A, Khoury H, Flowers C, Kaufman J, Lonial S, Lechowicz M, Gleason C, Vaughn L, Waller E. Extracorporeal Photopheresis Therapy For Chronic Graft-Versus-Host Disease: Response Is Associated With Content Of Dendritic Cells And T-Cells In Peripheral Blood At Initiation Of Treatment Biology of Blood and Marrow Transplantation. 15: 128-129. DOI: 10.1016/j.bbmt.2008.12.393  0.208
2013 Tiwari D, Horan J, Langston A, Qayed M, Carr J, Renfroe H, Couture C, Khoury HJ, Robertson J, Harvey D, Mehta A, Waller EK, Kean LS. A First-in-Disease Trial of in Vivo Costimulation Blockade for GVHD Prevention: The Addition of Abatacept to Standard GVHD Prophylaxis Controls Early CD4+ T Cell Proliferation and is Associated with Low Rates of Severe Acute GVHD Biology of Blood and Marrow Transplantation. 19: S327-S328. DOI: 10.1016/J.BBMT.2012.11.497  0.208
2005 Kaufman J, Lonial S, Hicks M, Langston A, Flowers C, Lechowicz M, Khoury H, Waller E. Rituximab does not inhibit chemo-mobilization of HPC or engraftment following autologous transplant for lymphoma Biology of Blood and Marrow Transplantation. 11: 6. DOI: 10.1016/j.bbmt.2004.12.018  0.208
2005 Klein KR, Woodward CS, Waller EK, Lechowicz MJ, Rosenthal H. Effects of Mycotoxins on Mononuclear Cells (MNCs) in Normal Blood, T-Cell Leukemia and Lymphoma Cell Lines. Blood. 106: 4828-4828. DOI: 10.1182/blood.V106.11.4828.4828  0.208
2008 Waller EK, Li JM. Donor dendritic cells dance the do-si-do in allogeneic transplantation Blood. 112: 3007-3008. DOI: 10.1182/blood-2008-08-171306  0.207
2018 Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini PN, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, ... ... Waller EK, et al. Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30292009 DOI: 10.1016/J.Bbmt.2018.09.004  0.207
2015 Petersen CT, Darlak KA, Li J, Waller EK. Absence of Vasoactive Intestinal Peptide Signaling Significantly Enhances T Cell Survival Following MCMV Infection Via Increased Expression of Bcl-2 and Bcl-XL Blood. 126: 1028-1028. DOI: 10.1182/blood.v126.23.1028.1028  0.207
2008 Akhtari M, Lanston A, Waller E, Gal A. 389: Eosinophilic Pulmonary Syndrome as a Manifestation of Pulmonary Graft-versus-host-disease Following Hematopoietic Stem Cell Transplantation in Three Patients Biology of Blood and Marrow Transplantation. 14: 141. DOI: 10.1016/j.bbmt.2007.12.399  0.207
2013 Lill M, Costa LJ, Yeh RF, Lim S, Stuart R, Waller EK, Shore T, Craig M, Freytes CO, Shea TC, Rodriguez TE, Flinn IW, Comeau T, Yeager AM, Pulsipher MA, et al. Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America Biology of Blood and Marrow Transplantation. 19: S132. DOI: 10.1016/J.Bbmt.2012.11.067  0.206
1993 Waller EK, Ziemianska M, Bangs CD, Cleary M, Weissman I, Kamel OW. Characterization of posttransplant lymphomas that express T-cell-associated markers: Immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice Blood. 82: 247-261. PMID 8100721 DOI: 10.1182/Blood.V82.1.247.Bloodjournal821247  0.205
2010 Armand P, Perez W, Zhang M, Kim H, Klumpp TR, Cin PD, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz A, Gupta V, Savani BN, McCarthy PL, Cahn J, et al. Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study Blood. 116: 680-680. DOI: 10.1182/Blood.V116.21.680.680  0.205
2013 Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, ... ... Waller EK, et al. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. British Journal of Haematology. 162: 648-56. PMID 23829536 DOI: 10.1111/bjh.12451  0.205
2012 François M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing Cytotherapy. 14: 147-152. PMID 22029655 DOI: 10.3109/14653249.2011.623691  0.205
2011 Renfroe H, Arnold M, Vaughn L, Harvey RD, Hamilton E, Lonial S, Khoury HJ, Kaufman JL, Lechowicz MJ, Flowers CR, Waller EK. A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation. Transfusion. 51: 1779-83. PMID 21332729 DOI: 10.1111/j.1537-2995.2010.03052.x  0.205
2018 Gandelman JS, Song DJ, Chen H, Chen Y, Clark WB, Engelhardt BG, Giver CR, Waller EK, Jagasia M. A Prospective Trial of Extracorporeal Photopheresis (ECP) in the Modern Transplant Era Reveals Response and Decreased Steroid Doses for Patients with Chronic Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24: S180-S181. DOI: 10.1016/j.bbmt.2017.12.132  0.204
1996 Turner CW, Yeager AM, Waller EK, Wingard JR, Fleming WH. Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice. Blood. 87: 3237-44. PMID 8605339 DOI: 10.1182/Blood.V87.8.3237.Bloodjournal8783237  0.203
2007 Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy Oncologist. 12: 22-26. PMID 18039636 DOI: 10.1634/theoncologist.12-S2-22  0.203
2014 Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe LA, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SG, Petersdorf EW, Schultz K, ... ... Waller EK, et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 123: 1270-8. PMID 24408320 DOI: 10.1182/Blood-2013-10-532671  0.203
2016 Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Dixon MD, Langston AA, Nooka AK, Flowers CR, Pentz RD, Waller EK. Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital. Journal of Stem Cell Research & Therapy. 6. PMID 28966870 DOI: 10.4172/2157-7633.1000328  0.203
2016 Jaglowski S, Waller EK, Kindwall-Keller TL, McCarty JM, Dugan M, Yellin M, Davis T, Devine SM. Preliminary Safety and Efficacy Data Using CDX-301 (Flt3 ligand) As a Sole Agent to Mobilize Hematopoietic Cells Prior to HLA-Matched Sibling Donor Transplantation Biology of Blood and Marrow Transplantation. 22: S324-S325. DOI: 10.1016/J.BBMT.2015.11.801  0.203
2019 Waller EK, Miklos D, Cutler C, Arora M, Jagasia MH, Pusic I, Flowers MED, Logan AC, Nakamura R, Chang S, Clow F, Lal ID, Styles L, Jaglowski S. Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31260802 DOI: 10.1016/j.bbmt.2019.06.023  0.202
1991 Waller EK, Kamel OW, Cleary ML, Majumdar AS, Schick MR, Lieberman M, Weissman IL. Growth of primary T-cell non-Hodgkin's lymphomata in SCID-hu mice: Requirement for a human lymphoid microenvironment Blood. 78: 2650-2665. PMID 1824259 DOI: 10.1182/Blood.V78.10.2650.Bloodjournal78102650  0.202
2016 Chinnadurai R, Copland IB, Garcia MA, Petersen CT, Lewis CN, Waller EK, Kirk AD, Galipeau J. Cryopreserved MSCs are Susceptible to T-cell Mediated Apoptosis which is partly Rescued by IFNγ Licensing. Stem Cells (Dayton, Ohio). PMID 27299362 DOI: 10.1002/stem.2415  0.201
1998 Ship AM, Carter R, Murray T, Gurriero A, Waller EK. Irradiated Donor Lymphocyte Infusion, A Novel Approach To Prevent Graft Failure During Allogeneic Bone Marrow Transplant • 797 Pediatric Research. 43: 138-138. DOI: 10.1203/00006450-199804001-00818  0.201
2013 Nooka AK, Kaufman JL, Behera M, Langston A, Waller EK, Flowers CR, Gleason C, Boise LH, Lonial S. Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer. 119: 4119-28. PMID 24005889 DOI: 10.1002/Cncr.28325  0.199
2013 Yun HD, Waller EK. Finding the sweet spot for donor lymphocyte infusions Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 507-508. PMID 23416853 DOI: 10.1016/j.bbmt.2013.02.005  0.197
2008 Lonial S, Torre C, David E, Harris W, Arellano M, Waller EK. Regulation of alloimmune responses by dendritic cell subsets Experimental Hematology. 36: 1309-1317. PMID 18620796 DOI: 10.1016/j.exphem.2008.04.021  0.197
2012 Costa LJ, Lill M, Yeh RF, Stuart RK, Lim S, Waller EK, Shore TB, Craig M, Freytes CO, Shea TC, Rodriguez TE, Flinn IW, Comeau T, Pulsipher MA, Bence-Bruckler I, et al. Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America Blood. 120: 813-813. DOI: 10.1182/Blood.V120.21.813.813  0.197
2014 Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, ... ... Waller EK, et al. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1729-36. PMID 25008330 DOI: 10.1016/j.bbmt.2014.06.036  0.196
2015 Long G, Waller EK, Gregurek S, Tricot G, Marschner S, Bill J. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients. Journal of Clinical Apheresis. 30: 1-7. PMID 24941931 DOI: 10.1002/jca.21341  0.196
1992 Waller EK, Sen-Majumdar A, Kamel OW, Hansteen GA, Schick MR, Weissman IL. Human T-cell development in SCID-hu mice: Staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy Blood. 80: 3144-3156. PMID 1467521 DOI: 10.1182/Blood.V80.12.3144.Bloodjournal80123144  0.195
2016 Ballen K, Ahn KW, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, ... ... Waller EK, et al. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27343716 DOI: 10.1016/j.bbmt.2016.06.012  0.195
2002 Jurickova I, Waller EK, Yeager AM, Boyer MW. Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia Bone Marrow Transplantation. 30: 687-697. PMID 12420208 DOI: 10.1038/sj.bmt.1703718  0.194
2013 Vose JM, Friedberg JW, Waller EK, Cheson BD, Juvvigunta V, Fritsch H, Petit C, Munzert G, Younes A. The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study. Leukemia & Lymphoma. 54: 708-13. PMID 22978685 DOI: 10.3109/10428194.2012.729833  0.194
2012 Hossain MS, Gewirtz AT, Waller EK. Distinct IFN-Gamma Dependent Effect of the TLR5 Agonist, Flagellin On NK and CD4+ T Cell Immunity Against CMV Blood. 120: 255-255. DOI: 10.1182/Blood.V120.21.255.255  0.194
2013 Armand P, Nagler A, Weller EA, Devine SM, Avigan DE, Chen YB, Kaminski MS, Holland HK, Winter JN, Mason JR, Fay JW, Rizzieri DA, Hosing CM, Ball ED, Uberti JP, ... ... Waller EK, et al. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4199-206. PMID 24127452 DOI: 10.1200/JCO.2012.48.3685  0.194
1992 Lieberman M, Hansteen GA, Waller EK, Weissman IL, Sen-Majumdar A. Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis Journal of Experimental Medicine. 176: 399-405. PMID 1500852 DOI: 10.1084/jem.176.2.399  0.194
2006 Li J, Giver C, Gorechlad J, Larsen C, Waller E. Apoptotic donor leukocytes inhibit tolerance and limit mixed chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 12: 80. DOI: 10.1016/J.Bbmt.2005.11.250  0.193
1999 Ship AM, Waller EK. Clinical use of irradiated donor lymphocytes in bone marrow transplantation Cancer Treatment and Research. 101: 267-282. PMID 10800653  0.193
2012 Hsieh J, McGary C, Wu J, Paiardini M, Micci L, Garcia A, Silvestri G, Hossain MS, Waller EK, Galipeau J. A Novel Synthetic GMCSF and IL7 Fusion Cytokine (GIFT7) Leads to T Cell Neogenesis by Reversing Age-Related Thymic Atrophy and Overcoming PD-1-Assocaited CD8 Exhaustion Blood. 120: 3289-3289. DOI: 10.1182/Blood.V120.21.3289.3289  0.192
2000 Lonial S, Jones TW, Devine S, Winton EF, Heffner LT, Smith KJ, Yeager AM, Waller EK. High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma. Leukemia & Lymphoma. 36: 497-502. PMID 10784394 DOI: 10.3109/10428190009148397  0.192
2017 Shah NN, McClellan W, Flowers CR, Lonial S, Khoury H, Waller EK, Langston A, Nooka AK. Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study. Infection Control and Hospital Epidemiology. 1-7. PMID 28330512 DOI: 10.1017/Ice.2017.12  0.192
2012 Owonikoko TK, Harvey RD, Kauh JS, Lewis CM, Hossain MS, Akintayo AO, Merriewether AR, Chen Z, Hawk NN, Saba NF, Harris W, Shin DM, El-Rayes BF, Huang C, Lonial S, ... ... Waller EK, et al. A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies. Journal of Clinical Oncology. 30: 2576-2576. DOI: 10.1200/Jco.2012.30.15_Suppl.2576  0.192
1997 Holland HK, Brav RA, Otoole K, Holden JT, Connaghan PO, Heffiier LT, Waller EK, Winton EF, Yeager AM. Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS) Experimental Hematology. 25: 905.  0.191
2004 Hicks M, Lonial S, Langston A, Smith K, Mossavi Sai S, Hamilton E, Waller E. Optimization of chemo-mobilization of autologous blood hematopoietic progenitor cell grafts Biology of Blood and Marrow Transplantation. 10: 64-65. DOI: 10.1016/j.bbmt.2003.12.041  0.19
2018 Funk CR, Petersen CT, Jagirdar N, Ravindranathan S, Jaye DL, Flowers CR, Langston A, Waller EK. Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report. International Journal of Molecular Sciences. 19. PMID 30572564 DOI: 10.3390/ijms19124118  0.19
2012 Hailemichael E, Kaufman JL, Flowers CR, Waller EK, Lechowicz MJ, Langston A, Graiser M, Boise LH, Lonial S, Nooka AK. Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry Blood. 120: 2072-2072. DOI: 10.1182/Blood.V120.21.2072.2072  0.19
2017 McGuirk J, Waller EK, Qayed M, Abhyankar S, Ericson S, Holman P, Keir C, Myers GD. Building blocks for institutional preparation of CTL019 delivery. Cytotherapy. PMID 28754600 DOI: 10.1016/j.jcyt.2017.06.001  0.189
2018 Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE. Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion. Nature Communications. 9: 3698. PMID 30209264 DOI: 10.1038/s41467-018-05853-7  0.188
2019 Owonikoko TK, Higgins KA, Chen Z, Zhang C, Pillai RN, Steuer CE, Saba NF, Pakkala S, Shin DM, Zhang G, Wang S, Hossain MS, Beardslee T, Engelhart A, Revenig J, ... ... Waller EK, et al. A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC). Journal of Clinical Oncology. 37: 8515-8515. DOI: 10.1200/Jco.2019.37.15_Suppl.8515  0.188
2004 Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients Bone Marrow Transplantation. 33: 543-548. PMID 14730342 DOI: 10.1038/sj.bmt.1704408  0.188
1999 Waller EK, Barlett N, Chen CH, Mujic V, Sussman H, Toepker S, Grenier K. Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy Cytotherapy. 1: 21-29. PMID 19746646  0.187
2017 Islam M, Brink H, Blanche S, DiPrete C, Bongiorno T, Stone N, Liu A, Philip A, Wang G, Lam W, Alexeev A, Waller EK, Sulchek T. Microfluidic Sorting of Cells by Viability Based on Differences in Cell Stiffness. Scientific Reports. 7: 1997. PMID 28515450 DOI: 10.1038/S41598-017-01807-Z  0.186
2002 Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK. The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation Experimental Hematology. 30: 1044-1050. PMID 12225796 DOI: 10.1016/S0301-472X(02)00878-0  0.185
2006 Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Lechowicz MJ, Waller EK. Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma Leukemia and Lymphoma. 47: 2155-2162. PMID 17071490 DOI: 10.1080/10428190600774923  0.185
2000 Lopez RD, Xu S, Guo B, Negrin RS, Waller EK. CD2-mediated IL-12-dependent signals render human γδ-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: Implications for the development of adoptive immunotherapy strategies Blood. 96: 3827-3837. PMID 11090067  0.184
2020 Islam M, Raj A, McFarland B, Brink HM, Ciciliano J, Fay M, Myers DR, Flowers C, Waller EK, Lam W, Alexeev A, Sulchek T. Stiffness based enrichment of leukemia cells using microfluidics. Apl Bioengineering. 4: 036101. PMID 32637856 DOI: 10.1063/1.5143436  0.184
2017 Forghani P, Petersen CT, Waller EK. Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity. Oncotarget. 8: 81873-81879. PMID 29137229 DOI: 10.18632/oncotarget.20704  0.184
2013 Forghani P, Harris W, Giver CR, Mirshafiey A, Galipeau J, Waller EK. Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice. Plos One. 8: e64837. PMID 23843936 DOI: 10.1371/journal.pone.0064837  0.183
2010 Zhang H, Graiser M, Hutcherson D, Dada MO, McMillan S, Zahir A, Flowers CR, Waller E. Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation Blood. 116: 1359-1359. DOI: 10.1182/blood.v116.21.1359.1359  0.183
2012 Mavromatis K, Sutcliffe DJ, Joseph G, Alexander RW, Waller EK, Quyyumi AA, Taylor WR. Proangiogenic cell colonies grown in vitro from human peripheral blood mononuclear cells. Journal of Biomolecular Screening. 17: 1128-35. PMID 22904201 DOI: 10.1177/1087057112457043  0.182
2014 Hossain MS, Ramachandiran S, Gewirtz AT, Waller EK. Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice. Plos One. 9: e96165. PMID 24879439 DOI: 10.1371/Journal.Pone.0096165  0.181
2016 Hayek SS, Klyachkin Y, Asfour A, Ghasemzadeh N, Awad M, Hesaroieh I, Ahmed H, Gray B, Kim J, Waller EK, Quyyumi AA, Abdel-Latif AK. Bioactive Lipids and Circulating Progenitor Cells in Patients With Cardiovascular Disease. Stem Cells Translational Medicine. PMID 27742846 DOI: 10.5966/sctm.2016-0059  0.18
2012 Kean L, Langston A, Qayed M, Khoury J, Tiwari D, Couture C, Renfroe H, Sen S, Robertson J, Waller E, Horan J. CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GVHD During High-Risk Unrelated HSCT: A First-In-Disease Trial Biology of Blood and Marrow Transplantation. 18: S365. DOI: 10.1016/j.bbmt.2011.12.429  0.179
2018 Gandelman J, Song D, Chen H, Engelhardt B, Chen Y, Clark W, Giver C, Waller E, Jagasia M. 386 Regulatory cells may not be the answer: A prospective study of ECP in cGVHD Journal of Investigative Dermatology. 138: S66. DOI: 10.1016/J.Jid.2018.03.393  0.179
2011 Li JM, Southerland L, Hossain MS, Giver CR, Wang Y, Darlak K, Harris W, Waschek J, Waller EK. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. Journal of Immunology (Baltimore, Md. : 1950). 187: 1057-65. PMID 21677142 DOI: 10.4049/Jimmunol.1100686  0.179
1997 Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning Blood. 90: 5013-5021. PMID 9389721  0.178
2019 Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, Waller EK, Burke E, Skerrett D, Shpall E, Martin PJ. A Phase 3 randomized study of Remestemcel-L versus placebo added to second line therapy in patients with steroid refractory acute graft versus host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31505228 DOI: 10.1016/j.bbmt.2019.08.029  0.178
2018 Bishop MR, Maziarz RTT, Waller EK, del Corral C, Tiwari R, Anak Ö, Awasthi R, Romanov VV, Schuster SJ. Safety and Efficacy of Tisagenlecleucel Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) and No Evidence of Active Disease Following Bridging Chemotherapy in the JULIET Trial Blood. 132: 2958-2958. DOI: 10.1182/BLOOD-2018-99-115094  0.178
1993 Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 74: 833-43. PMID 8104101 DOI: 10.1016/0092-8674(93)90463-Z  0.177
2008 Lonial S, Kaufman J, Torre C, Langston A, Lechowicz MJ, Flowers C, McMillan S, Renfroe H, Heffner LT, Waller EK. A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration. Blood. 112: 3332-3332. DOI: 10.1182/BLOOD.V112.11.3332.3332  0.177
2016 Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Alousi AM, Horowitz MM, Abhyankar S, Waller EK, Mendizabal A, Wang Y, Lazaryan A, et al. Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network Biology of Blood and Marrow Transplantation. 22: S50-S52. DOI: 10.1016/J.Bbmt.2015.11.336  0.177
2000 Boyer MW, Waller EK, Bray RA, Unangst T, Johnson TS, Phillips C, Jurickova I, Winton EF, Yeager AM. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells Leukemia. 14: 412-418. PMID 10720135  0.177
2017 Joseph N, Kaufman J, Boise L, Almaula D, Langston A, Waller E, Khoury H, Heffner LT, Lonial S, Nooka A. Safety and Engraftment Parameters for Bloodless Transplants among Myeloma Patients Clinical Lymphoma Myeloma and Leukemia. 17: e68-e69. DOI: 10.1016/J.Clml.2017.03.124  0.176
2019 Moazzami K, Lima BB, Hammadah M, Ramadan R, Al Mheid I, Kim JH, Alkhoder A, Obideen M, Levantsevych O, Shah A, Liu C, Bremner JD, Kutner M, Sun YV, Waller EK, et al. Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease. Jama Cardiology. PMID 31799987 DOI: 10.1001/Jamacardio.2019.4528  0.176
2015 Hassan MN, Waller EK. GVHD clears the Aire in thymic selection Blood. 125: 2593-2595. PMID 25907903  0.176
2014 Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, ... ... Waller EK, et al. Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1. Bone Marrow Transplantation. 49: 1176-83. PMID 24955785 DOI: 10.1038/Bmt.2014.122  0.175
2008 Hessel A, Tselanyane M, Wang F, David E, Lonial S, Waller EK. Patulin Acts Synergistically with Doxorubicin and Bortezomib in Cytotoxicity against Hematological Malignancies Blood. 112: 2664-2664. DOI: 10.1182/blood.V112.11.2664.2664  0.175
1997 Guerriero A, Worford L, Holland HK, Guo GR, Sheehan K, Waller EK. Thrombopoietin is synthesized by bone marrow stromal cells. Blood. 90: 3444-55. PMID 9345028  0.175
2017 Petersen CT, Li JM, Waller EK. Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia. Oncoimmunology. 6: e1304336. PMID 28638725 DOI: 10.1080/2162402X.2017.1304336  0.174
1998 Kourtis AP, Lee FK, Ibegbu C, Waller E, Nahmias AJ. An in vitro system of T cell maturation-effect of cytokines and of thymic epithelial cells ♦ 865 Pediatric Research. 43: 150-150. DOI: 10.1203/00006450-199804001-00886  0.174
2012 Matulis SM, Liu J, Gupta VA, Conage-Pough JE, Nooka AK, Waller EK, Kaufman JL, Lonial S, Boise LH. Interleukin-6 Enhances the Survival of Myeloma Cells by Regulating Bim Binding to Anti-Apoptotic Bcl-2 Proteins Blood. 120: 4024-4024. DOI: 10.1182/Blood.V120.21.4024.4024  0.173
2014 Kaliyaperumal S, Sharma P, Watkins BK, Furlan SN, Ramakrishnan S, Giver C, Garcia A, Courtney C, Hamby K, Garrett A, Deane T, Strobert E, Jenkins J, Elder E, Eishiavielli N, ... ... Waller EK, et al. CD8-Predominant T Cell Meningitis Accompanies Gvhd in Primates and Is Prevented with Immunoprophylaxis Biology of Blood and Marrow Transplantation. 20: S270-S272. DOI: 10.1016/J.Bbmt.2013.12.455  0.173
2009 Li J, Darlak K, Lu Y, Harris W, Jaye D, Waller E. Donor Dendritic Cells Initiate Counter-Regulatory Immune Responses And GvL Effects In Alllogeneic BMT Biology of Blood and Marrow Transplantation. 15: 119. DOI: 10.1016/j.bbmt.2008.12.366  0.173
2015 Napier RJ, Norris BA, Swimm A, Giver CR, Harris WA, Laval J, Napier BA, Patel G, Crump R, Peng Z, Bornmann W, Pulendran B, Buller RM, Weiss DS, Tirouvanziam R, ... Waller EK, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770. PMID 25822986 DOI: 10.1371/Journal.Ppat.1004770  0.172
2016 Jagasia MH, Basu T, Engelhardt BG, Chen H, Clark W, Waller EK, Giver C, Chen Y, Savani BN, Kassim AA, Jung DK, Polikowsky H, Benmebarek R, Heck S, Ellis R, et al. Single Cell Mass Cytometry Identifies T-Regulatory Cell Subsets Associated with ECP Response in Chronic GVHD Biology of Blood and Marrow Transplantation. 22: S400-S401. DOI: 10.1016/J.Bbmt.2015.11.928  0.172
2005 Lonial S, Waller EK, Richardson PG, Jagannath S, Orlowski RZ, Giver CR, Jaye DL, Barlogie B, Heffner LT, Anderson KC. Bortezomib-associated transient and cyclical thrombocytopenia: evidence for lack of marrow cytotoxicity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6610. PMID 27944269 DOI: 10.1200/jco.2005.23.16_suppl.6610  0.171
2019 Ravindranathan S, Jajja MR, Waller A, Bommireddy R, Petersen C, Selvaraj P, Yang L, Lesinski GB, El-Rayes BF, Flynn B, Waller EK. Personalized T cell therapy for metastatic colon cancer. Journal of Clinical Oncology. 37: e15183-e15183. DOI: 10.1200/JCO.2019.37.15_SUPPL.E15183  0.171
2005 Jabs A, Moncada GA, Nichols CE, Waller EK, Wilcox JN. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue Journal of Vascular Research. 42: 174-180. DOI: 10.1159/000084406  0.171
2015 Zhang J, Mosunjac M, Moon A, Nooka A, Waller EK. Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges. Bone Marrow Transplantation. 50: 465-8. PMID 25581407 DOI: 10.1038/Bmt.2014.289  0.17
2011 Hossain M, Gewirtz A, Roback J, Waller E. Flagellin Reduces GvHD Through Early Immunosuppression Induced by the flagellin-TLR5 Immune Interaction of Host Cells in Allogeneic HSCT Recipients Biology of Blood and Marrow Transplantation. 17: S303. DOI: 10.1016/J.Bbmt.2010.12.447  0.17
2018 Samman Tahhan AS, Hammadah M, Raad M, Almuwaqqat Z, Alkhoder A, Sandesara PB, Kelli H, Hayek SS, Kim JH, O'Neal WT, Topel ML, Grant AJ, Sabbak N, Heinl RE, Gafeer MM, ... ... Waller EK, et al. Progenitor Cells and Clinical Outcomes in Patients with Acute Coronary Syndromes. Circulation Research. PMID 29514830 DOI: 10.1161/Circresaha.118.312821  0.17
2000 Redei I, Längsten AA, Cherry JK, Hamilton ES, Jones ML, Waller EK. Effective T cell depletion of G-CSF mobilized haploidentical PBSC graft with combined positive/ negative immunomagnetic selection using isolex 300i system version 2.5 Blood. 96.  0.17
2008 August K, Chiang K, Bostick R, Waller E, Langston A, Khoury H, Moore K, Worthington-White D, Rowland P, Horan J. 363: Early Detection of Severe Acute Graft-Versus-Host Disease using Plasma Markers of T-cell Activation Biology of Blood and Marrow Transplantation. 14: 133. DOI: 10.1016/J.Bbmt.2007.12.373  0.17
2017 Chinnadurai R, Rajan D, Ng S, McCullough K, Arafat D, Waller EK, Anderson LJ, Gibson G, Galipeau J. Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming. Blood Advances. 1: 628-643. PMID 28713871 DOI: 10.1182/bloodadvances.2017006205  0.17
2013 Hossain MS, El-Najjar VF, Jaye DL, Ahmed R, Waller EK. Expression Of PD-L1 Is Required To Control Acute GvHD In Allo-HSCT Recipients Blood. 122: 2008-2008. DOI: 10.1182/Blood.V122.21.2008.2008  0.169
2012 Jaye DL, Bray RA, Gebel HM, Harris WA, Waller EK. Translational applications of flow cytometry in clinical practice. Journal of Immunology (Baltimore, Md. : 1950). 188: 4715-9. PMID 22556132 DOI: 10.4049/jimmunol.1290017  0.169
2020 Eberhardt CS, Wieland A, Nasti TH, Grifoni A, Wilson E, Schmid DS, Pulendran B, Sette A, Waller EK, Rouphael N, Ahmed R. Persistence of varicella zoster virus specific plasma cells in adult human bone marrow following childhood vaccination. Journal of Virology. PMID 32321817 DOI: 10.1128/Jvi.02127-19  0.168
2017 Koff J, Li J, Zhang X, Switchenko J, Flowers C, Waller E. Impact of post-transplant lymphoproliferative disorder subtype on survival Hematological Oncology. 35: 347-348. DOI: 10.1182/Blood.V130.Suppl_1.1578.1578  0.168
1995 Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen L. The "common stem cell" hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors Blood. 85: 2422-2435. PMID 7537114  0.168
2012 Kumar M, Nooka AK, Langston A, Gleason C, Watson M, Collins H, Casbourne D, Boise LH, Kaufman JL, Waller EK, Lonial S. Impact of Body Mass Index (BMI) On Overall Survival in Myeloma Blood. 120: 4289-4289. DOI: 10.1182/Blood.V120.21.4289.4289  0.168
1995 Waller EK, Huang S, Terstappen L. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development Blood. 86: 710-718. PMID 7541673  0.167
2012 Forghani P, Khorramizadeh MR, Waller EK. Natural suppressor cells; Past, present and future Frontiers in Bioscience - Elite. 4: 1237-1245. PMID 22201949  0.167
2011 Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh BJ, Gregory D, Werner A, et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal. 161: 98-105. PMID 21167340 DOI: 10.1016/J.Ahj.2010.09.025  0.167
2015 Deng J, Pennati A, Yuan S, Waller E, Lonial S, Roy K, Galipeau J. Fusokine GIFT4 triggers novel B Cell function on hematopoietic stem cells Cytotherapy. 17: S13-S14. DOI: 10.1016/J.Jcyt.2015.03.329  0.167
2015 Patel RS, Li Q, Ghasemzadeh N, Eapen DJ, Moss LD, Janjua AU, Manocha P, Al Kassem H, Veledar E, Samady H, Taylor WR, Zafari AM, Sperling L, Vaccarino V, Waller EK, et al. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. Circulation Research. 116: 289-97. PMID 25323857 DOI: 10.1161/Circresaha.116.304187  0.167
2013 Yun HD, Waller EK. Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia Blood. 122: 474. PMID 24049774 DOI: 10.1182/blood-2013-02-481697  0.166
2013 Copland IB, Garcia MA, Waller EK, Roback JD, Galipeau J. The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. Biomaterials. 34: 7840-50. PMID 23891515 DOI: 10.1016/j.biomaterials.2013.06.050  0.166
2009 Hossain M, Roback J, Gewirtz A, Waller E. Flagellin, A TLR5 Agonist, Facilitates Production of foxp3+CD4+CD25+ Regulatory T Cells to Maintain Balanced Immune Reconstitution in Allogeneic BMT without GvHD Biology of Blood and Marrow Transplantation. 15: 12. DOI: 10.1016/J.Bbmt.2008.12.035  0.164
2016 Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Lal I, Dubovsky J, James DF, Styles L, et al. Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft Versus Host Disease (cGVHD) after Failure of Corticosteroids Blood. 128: LBA-3-LBA-3. DOI: 10.1182/Blood.V128.22.Lba-3.Lba-3  0.164
2005 Gladney SP, Heffner LT, Langston A, Holden J, Phillips C, Winton E, Flowers CR, Lechowicz MJ, Lonial S, Waller E, Khoury HJ. Patient Characteristics in CD 20+ and CD 20− Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis. Blood. 106: 4523-4523. DOI: 10.1182/blood.v106.11.4523.4523  0.163
2016 Hammadah M, Mheid IA, Obideen M, Abdelhadi N, Wilmot K, Ramadan R, Alkhoder A, Pimple PM, Fang S, Awad M, Levantsevych O, Kelli HM, Bouchi Y, Murrah N, Shah A, ... ... Waller E, et al. SHORTER TELOMERE LENGTH IS ASSOCIATED WITH LOWER LEVELS OF CIRCULATING PROGENITOR CELLS Journal of the American College of Cardiology. 67: 166. DOI: 10.1016/S0735-1097(16)30167-X  0.163
2000 Lopez RD, Waller EK, Lu PH, Negrin RS. CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells Cancer Immunology, Immunotherapy. 49: 629-640. PMID 11258789  0.163
2015 Copland IB, Qayed M, Garcia M, Galipeau J, Waller E. Bone marrow mesenchymal stromal cells from patients with acute and chronic gvhd deploy normal phenotype, differentiation plasticity and immune-suppressive activity Cytotherapy. 17: S39. DOI: 10.1016/j.jcyt.2015.03.437  0.163
2009 Akhtari M, Langston AA, Waller EK, Gal AA. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients Bone Marrow Transplantation. 43: 155-158. PMID 18794871 DOI: 10.1038/bmt.2008.302  0.163
1996 Waller EK. Irradiated allogene1c donor lymphocytes have an antileukemic effect in mice without producing graft vs. host disease Experimental Hematology. 24: 1092.  0.162
2013 Poole J, Mavromatis K, Binongo JN, Khan A, Li Q, Khayata M, Rocco E, Topel M, Zhang X, Brown C, Corriere MA, Murrow J, Sher S, Clement S, Ashraf K, ... ... Waller EK, et al. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial. Jama. 310: 2631-9. PMID 24247554 DOI: 10.1001/Jama.2013.282540  0.16
2008 Langston AA, Murali S, McMillan S, Heffner LT, Lonial S, Waller EK, Flowers CR, Kaufman J, McLemore ML, Sinha R, Lechowicz MJ, Khoury HJ, Winton EF. Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study Blood. 112: 3644-3644. DOI: 10.1182/blood.v112.11.3644.3644  0.16
2007 Schuster MW, Mehta J, Waller E, Rifkin R, Micallef I, Hurd D, Parekh S, Hari P, Skikne B, Shea T, Frei-Lahr D, Abonour R, Freytes C, Pineiro L, Halvorsen Y, et al. A Randomized Placebo Controlled Phase II Trial of Prevention of Severe Oral Mucositis Using Single Dose Velafermin in Patients Receiving Myeloablative Therapy and Autologous Hematopoietic Stem Cell Transplant (AHSCT). Blood. 110: 615-615. DOI: 10.1182/BLOOD.V110.11.615.615  0.16
2020 Maziarz RT, Waller EK, Jaeger U, Fleury I, McGuirk J, Holte H, Jaglowski S, Schuster SJ, Bishop MR, Westin JR, Mielke S, Teshima T, Bachanova V, Foley SR, Borchmann P, et al. Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Advances. 4: 629-637. PMID 32074277 DOI: 10.1182/bloodadvances.2019001026  0.159
2018 Sahaf B, Tebaykin D, Hopper M, Cheung P, Bittencourt F, Cutler C, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Jaglowski S, Lih J, Solman I, et al. Ibrutinib-Mediated Inhibition of cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells Biology of Blood and Marrow Transplantation. 24: S20-S21. DOI: 10.1016/J.Bbmt.2017.12.007  0.159
2017 Mahar EA, Mou L, Hayek SS, Quyyumi AA, Waller EK. Flow cytometric data analysis of circulating progenitor cell stability. Data in Brief. 10: 346-348. PMID 28004026 DOI: 10.1016/j.dib.2016.11.050  0.159
2014 Roback JD, Josephson CD, Waller EK, Newman JL, Karatela S, Uppal K, Jones DP, Zimring JC, Dumont LJ. Metabolomics of ADSOL (AS-1) red blood cell storage. Transfusion Medicine Reviews. 28: 41-55. PMID 24636780 DOI: 10.1016/J.Tmrv.2014.01.003  0.159
2014 McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, ... ... Waller EK, et al. Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 960-8. PMID 24641829 DOI: 10.1016/J.Bbmt.2014.03.013  0.159
2014 Forghani P, Waller EK. New Mechanism in Anti Tumor Activity of Poly (I:C): Modulation of Tumor-Associated Myeloid Derived Suppressor Cells in Murine Model of Breast Cancer Blood. 124: 2728-2728. DOI: 10.1182/blood.V124.21.2728.2728  0.158
2018 Samman-Tahhan AS, Hammadah M, Kelli HM, Kim JH, Sandesara PB, Alkhoder A, Kaseer B, Gafeer MM, Topel ML, Hayek SS, O'Neal WT, Obideen M, Ko YA, Liu C, Hesaroieh I, ... ... Waller EK, et al. Circulating Progenitor Cells and Racial Differences: A Possible Contribution to Health Disparity. Circulation Research. PMID 29930146 DOI: 10.1161/Circresaha.118.313282  0.158
1994 Sen-Majumdar A, Weissman IL, Hansteen G, Marian J, Waller EK, Lieberman M. Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor Vβ gene products Journal of Virology. 68: 1165-1172. PMID 8289345 DOI: 10.1128/Jvi.68.2.1165-1172.1994  0.157
2018 Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK. Impact of the posttransplant lymphoproliferative disorder subtype on survival. Cancer. PMID 29579330 DOI: 10.1002/Cncr.31339  0.156
2003 Waller EK, Ernstoff MS. Modulation of antitumor immune responses by hematopoietic cytokines Cancer. 97: 1797-1809. PMID 12655538 DOI: 10.1002/cncr.11247  0.156
2005 Chahroudi A, Chavan R, Kozyr N, Koyzr N, Waller EK, Silvestri G, Feinberg MB. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. Journal of Virology. 79: 10397-407. PMID 16051832 DOI: 10.1128/Jvi.79.16.10397-10407.2005  0.156
2015 Jagirdar N, Harvey RD, Nooka A, Flowers C, Kaufman J, Lonial S, Lechowicz MJ, Langston A, Lipscomb C, Gaylor C, Waller EK. Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion. 55: 2351-7. PMID 26331348 DOI: 10.1111/trf.13186  0.155
2013 Sinha R, Shenoy PJ, King N, Lechowicz MJ, Bumpers K, Hutcherson D, Arellano M, Langston A, Kaufman J, Heffner LT, Waller EK, Nooka A, Flowers CR, Lonial S. Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical Lymphoma, Myeloma & Leukemia. 13: 657-63. PMID 24094894 DOI: 10.1016/j.clml.2013.05.007  0.155
2013 Kozyr N, Ramakrishnan S, Polnett A, Hamby K, Tiwari D, Watkins B, Deane T, Stempora L, Elder E, Esiashvili N, Jenkins J, Strobert E, Garcia A, Sharma P, Courtney C, ... ... Waller EK, et al. Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade Biology of Blood and Marrow Transplantation. 19: S139. DOI: 10.1016/j.bbmt.2012.11.079  0.155
2006 Waller EK. A tale of two T cells: Suppressor CD8 T cells recalled to life Blood. 107: 4203-4204. DOI: 10.1182/blood-2006-03-008391  0.154
2013 Li JM, Darlak KA, Southerland L, Hossain MS, Jaye DL, Josephson CD, Rosenthal H, Waller EK. VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice. Plos One. 8: e63381. PMID 23723978 DOI: 10.1371/journal.pone.0063381  0.153
2013 Mikell J, Waller E, Rangaraju S, Switchenko J, Ali Z, Graiser M, Hall W, Langston A, Esiashvili N, Khan M. Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia International Journal of Radiation Oncology*Biology*Physics. 87: S558. DOI: 10.1016/J.Ijrobp.2013.06.1478  0.153
2013 Li J, Petersen CT, Darlak KA, Yun HD, Blazar BR, Waller EK. VIP-Receptor Antagonist Enhanced Antileukemic Activity In Mice Blood. 122: 1664-1664. DOI: 10.1182/Blood.V122.21.1664.1664  0.153
2006 Arellano M, Flowers C, Waller E, Lonial S, Kaufman J, Winton E, Khoury H, Langston A. Reduced-intensity conditioning permits a significant graft vs leukemia (GvL) effect for acute leukemia Biology of Blood and Marrow Transplantation. 12: 69-70. DOI: 10.1016/j.bbmt.2005.11.218  0.152
2006 Hamilton E, Flowers C, Vaughn M, Minerley M, Waller E. Receiver operator characteristics of the Sysmex HPC measurement used to initiate apheresis of blood hematopoietic progenitor cells Biology of Blood and Marrow Transplantation. 12: 10. DOI: 10.1016/j.bbmt.2005.11.034  0.151
2009 Akhtari M, Waller EK, Jaye DL, Lawson DH, Ibrahim R, Papadopoulos NE, Arellano ML. Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 322-4. PMID 19242368 DOI: 10.1097/CJI.0b013e31819aa40b  0.151
2010 Martin P, Uberti J, Soiffer R, Klingemann H, Waller E, Daly A, Herrmann R, Kebriaei P. Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD Biology of Blood and Marrow Transplantation. 16: S169-S170. DOI: 10.1016/J.BBMT.2009.12.057  0.151
2019 Bishop MR, Maziarz RT, Waller EK, Jäger U, Westin JR, McGuirk JP, Fleury I, Holte H, Borchmann P, Del Corral C, Tiwari R, Anak Ö, Awasthi R, Pacaud L, Romanov VV, et al. Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Advances. 3: 2230-2236. PMID 31332046 DOI: 10.1182/bloodadvances.2019000151  0.15
2015 Furlan SN, Watkins BK, Mortari A, Blazar BR, Giver C, Waller EK, Kean LS. Defining the Primate T Cell Transcriptome during GvHD: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in GvHD Pathogenesis and Prevention Biology of Blood and Marrow Transplantation. 21: S56. DOI: 10.1016/J.Bbmt.2014.11.055  0.15
2014 Hosoba S, Waller EK. New molecule for mobilizing marrow stem cells Blood. 123: 310-311. PMID 24434996 DOI: 10.1182/blood-2013-12-538249  0.149
2010 Li J, Shin K, Southerland L, Hossain S, Harris W, Waschek J, Waller E. The Absence Of Vasoactive Intestinal Peptide Augments Allo-Reactivity And The Anti-Viral Response In A Bone Marrow Transplant Setting Biology of Blood and Marrow Transplantation. 16: S223-S224. DOI: 10.1016/J.Bbmt.2009.12.212  0.148
1993 Kraft DL, Weissman IL, Waller EK. Differentiation of CD3-4-8- human fetal thymocytes in vivo: Characterization of a CD3- 4+ 8- intermediate Journal of Experimental Medicine. 178: 265-277. PMID 8315382 DOI: 10.1084/Jem.178.1.265  0.148
2018 Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, et al. A phase II/III randomized, multicenter trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for treatment of chronic graft-versus-host disease: BMT CTN 0801. Haematologica. PMID 29954931 DOI: 10.3324/Haematol.2018.195123  0.148
2006 Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms Modern Pathology. 19: 1555-1562. PMID 16998465 DOI: 10.1038/modpathol.3800679  0.146
2015 Flowers CR, Brown JR, Rosenthal H, Stock W, Katzen HI, Cohen JB, Sinha R, Lakhanpal S, Leis JF, Waller EK, Jaye DL. A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia. Clinical Lymphoma, Myeloma & Leukemia. PMID 26385641 DOI: 10.1016/j.clml.2015.07.640  0.145
2014 Pasquini MC, Le Rademacher J, Flowers C, Lill M, Costa LJ, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, ... ... Waller EK, et al. Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma Biology of Blood and Marrow Transplantation. 20: S162. DOI: 10.1016/J.Bbmt.2013.12.259  0.145
2009 Kaufman J, Lonial S, Sinha R, Torre C, Langston A, Lechowicz M, Flowers C, McMillan S, Renfroe H, Heffner L, Waller E. A364 A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma Clinical Lymphoma and Myeloma. 9: S60. DOI: 10.1016/S1557-9190(11)70559-5  0.145
2015 Petersen C, Li J, Waller E. Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P238  0.144
2016 Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, ... ... Waller EK, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Journal For Immunotherapy of Cancer. 4: 90. PMID 28018601 DOI: 10.1186/s40425-016-0188-z  0.144
2013 Waller EK, Johnson HR, Jagirdar N, Gaylor C, Lipscomb C, Flowers C, Kaufman J, Khoury HJ, Langston A, Lechowicz M, Lonial S, Nooka A, Sinha R, Harvey RD. Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells Biology of Blood and Marrow Transplantation. 19: S191. DOI: 10.1016/j.bbmt.2012.11.195  0.144
2012 Wang Y, Fan KT, Li JM, Waller EK. The regulation and activity of interleukin-12. Frontiers in Bioscience (Scholar Edition). 4: 888-99. PMID 22202097  0.144
2010 Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston AA, Heffner LT, Torre C, McMillan S, Renfroe H, Harvey RD, Lechowicz MJ, Khoury HJ, Flowers CR, Waller EK. A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5079-86. PMID 20739431 DOI: 10.1158/1078-0432.CCR-10-1662  0.144
1985 Waller EK, Schleuning WD. Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis Journal of Biological Chemistry. 260: 6354-6360. PMID 4039726  0.143
2005 David E, Sun SY, Waller EK, Chen J, Khuri FR, Lonial S. The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT. Blood. 106: 4322-9. PMID 16118318 DOI: 10.1182/blood-2005-06-2584  0.143
2019 Waller EK. The Hematopoietic Microenvironment: Heterogeneity of Bone Marrow Stromal Cells: Growth Properties and Cytokine Production by CD34+ and CD34- Stromal Sub-Sets. Hematology (Amsterdam, Netherlands). 4: 47-58. PMID 11399552 DOI: 10.1080/10245332.1999.11746430  0.142
2018 Akce M, Zaidi MY, Waller EK, El-Rayes BF, Lesinski GB. The Potential of CAR T Cell Therapy in Pancreatic Cancer. Frontiers in Immunology. 9: 2166. PMID 30319627 DOI: 10.3389/fimmu.2018.02166  0.141
2015 Forghani P, Waller EK. MYd88 Blockade Caused Reduction of PDL1 on Tumor Infiltrating MDSCs in a Murine Model of Melanoma Blood. 126: 1012-1012. DOI: 10.1182/blood.V126.23.1012.1012  0.141
2015 Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, Burdelya LG, Grossniklaus HE. The toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget. PMID 26655090 DOI: 10.18632/Oncotarget.6500  0.14
2010 Tran H, Arellano M, Chamsuddin A, Flowers C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton EF, Khoury HJ. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia & Lymphoma. 51: 1473-7. PMID 20443681 DOI: 10.3109/10428194.2010.481065  0.139
2018 Liu A, Islam M, Stone N, Varadarajan V, Jeong J, Bowie S, Qiu P, Waller EK, Alexeev A, Sulchek T. Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules. Materials Today (Kidlington, England). 21: 703-712. PMID 30288138 DOI: 10.1016/J.Mattod.2018.03.002  0.139
2010 Giver CR, Nix D, Jaye DL, Waller EK, Lonial S. Thrombocytopenia Induced by Combination Administration of Romidepsin and Bortezomib In Mice Is Rapidly Reversible After Drug Treatment Blood. 116: 4909-4909. DOI: 10.1182/blood.v116.21.4909.4909  0.138
2018 Cutler C, Jaglowski S, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Clow F, Chang S, Sukbuntherng J, Lal ID, Dubovsky J, Styles L, et al. Ibrutinib for Chronic Graft-Versus-Host Disease: A Safety and Pharmacokinetic Analysis in Patients Treated with Concomitant Antifungal CYP3A Inhibitors or Immunosuppressants Biology of Blood and Marrow Transplantation. 24: S186-S187. DOI: 10.1016/J.Bbmt.2017.12.139  0.138
2018 Rashidi A, Shanley R, Holtan SG, MacMillan ML, Yohe S, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller JS, Blazar BR, Weisdorf DJ. Single Nucleotide Polymorphisms of Paneth Cell Antimicrobial Alpha Defensin-5 (DEFA5) are Associated with Acute Graft-Versus-Host Disease: Results From Analysis of BMT-CTN0201 Samples Biology of Blood and Marrow Transplantation. 24: S174-S175. DOI: 10.1016/J.Bbmt.2017.12.124  0.136
2015 Forghani P, Waller EK. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer. Breast Cancer Research and Treatment. 153: 21-30. PMID 26208484 DOI: 10.1007/s10549-015-3508-y  0.135
2002 Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. The American Journal of Pathology. 160: 2145-55. PMID 12057918 DOI: 10.1016/S0002-9440(10)61163-7  0.135
2015 Hayek S, Tahhan AS, Yadalam A, MacNamara J, Awad M, Mheid IA, LI Q, Waller E, Quyyumi A. LOW ENDOTHELIAL PROGENITOR CELL (CD34+/VEGFR2+) COUNT IS AN INDEPENDENT PREDICTOR OF PERIPHERAL ARTERIAL DISEASE Journal of the American College of Cardiology. 65: A2116. DOI: 10.1016/S0735-1097(15)62116-7  0.135
2014 Forghani P, Khorramizadeh MR, Waller EK. Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Medicine. 3: 215-24. PMID 24574320 DOI: 10.1002/cam4.186  0.135
2019 Moazzami K, Lima B, Hammadah M, Alkhoder A, Ghaini I, Levantsevych O, Shah A, Bremner D, Kim J, Waller E, Vaccarino V, Quyyumi A. CHANGE IN CIRCULATING PROGENITOR CELLS DURING STRESS TESTING AND RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 73: 155. DOI: 10.1016/S0735-1097(19)30763-6  0.135
2011 Sinha R, King N, Shenoy PJ, Lechowicz MJ, Bumpers K, Hutcherson D, Arellano M, Langston A, Kaufman JL, Heffner LT, Waller EK, Flowers CR, Lonial S. Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL) Blood. 118: 1628-1628. DOI: 10.1182/BLOOD.V118.21.1628.1628  0.135
2005 Lonial S, Waller EK, Richardson PG, Jagannath S, Orlowski RZ, Giver CR, Jaye DL, Francis D, Giusti S, Torre C, Barlogie B, Berenson JR, Singhal S, Schenkein DP, Esseltine DL, et al. Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood. 106: 3777-84. PMID 16099887 DOI: 10.1182/blood-2005-03-1173  0.135
2017 Kersh AE, Ng S, Chang YM, Sasaki M, Thomas SN, Kissick HT, Lesinski GB, Kudchadkar RR, Waller EK, Pollack BP. Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer. Journal of Clinical Pharmacology. PMID 29136276 DOI: 10.1002/jcph.1028  0.134
2009 Lu Y, Li J, Harris W, Waller E. Interactions Between DC And T-Cells Initiate Counter-Regulatory Immune Activities That Limits Amplification Of Allo-Immune Responses And GvHD Biology of Blood and Marrow Transplantation. 15: 124. DOI: 10.1016/j.bbmt.2008.12.381  0.133
2015 DeFilipp Z, Purcell M, Harris WA, Chandra DJ, Gleason C, Wrammert J, Sarantopoulos S, Waller EK. Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. Bone Marrow Transplantation. PMID 26642338 DOI: 10.1038/bmt.2015.304  0.132
2011 Duan M, Marlow SD, Gaylor C, Wilburn R, Long GD, Drago S, Bill J, Waller EK. Comparison of the Efficiency CD34+ Cell Collection on the COBE Spectra and Cardian OPTIA Apheresis Platforms Blood. 118: 4395-4395. DOI: 10.1182/blood.V118.21.4395.4395  0.132
2011 Hossain S, Bhimani C, Chen Z, Ramalingam SS, Shin DM, Cohen C, Khuri FR, Waller E, Owonikoko TK. Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5585. PMID 28022083 DOI: 10.1200/Jco.2011.29.15_Suppl.5585  0.132
1999 Waller EK. Heterogeneity of bone marrow stromal cells: Growth properties and cytokine production by CD34+ and CD34- stromal sub-sets Hematology. 4: 47-58.  0.131
2002 Somani J, Lonial S, Rosenthal H, Resnick S, Kakhniashvili I, Waller EK. A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: Effect on cellular and humoral immune responses Vaccine. 21: 221-230.  0.13
2014 Ghasemzadeh N, De Staercke C, Li Q, Eapen D, Khayata M, Malekzadegan M, Smith GH, Alzaranah B, Mekonnen G, Alanbari R, Sperling L, Hooper C, Waller EK, Quyyumi A. STROMAL CELL-DERIVED FACTOR 1- AND CIRCULATING PROGENITOR CELL LEVELS AS PREDICTORS OF ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 63: A1589. DOI: 10.1016/S0735-1097(14)61592-8  0.13
2013 Chinnadurai R, Waller EK, Galipeau J, Nooka AK. From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases. Biomed Research International. 2013: 929842. PMID 24350294 DOI: 10.1155/2013/929842  0.13
2015 Hassan MN, Waller EK. Treating chemotherapy-induced thrombocytopenia: Is it timefor oncologists to use thrombopoietin agonists Oncology (United States). 29.  0.129
2019 Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE. Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion. Nature Communications. 10: 372. PMID 30655540 DOI: 10.1038/s41467-019-08400-0  0.129
2018 Awasthi R, Mueller KT, Yanik GA, Tam CS, Rives S, McGuirk JP, Pulsipher MA, Boyer MW, Jaeger U, Baruchel A, Myers GD, Balke-Want H, Schuster SJ, Stefanski H, Bishop MR, ... ... Waller EK, et al. Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients Blood. 132: 899-899. DOI: 10.1182/Blood-2018-99-116385  0.129
2012 Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplantation. 47: 1350-5. PMID 22327131 DOI: 10.1038/bmt.2011.261  0.128
2017 Khambhati J, Sandesara P, Tahhan AS, Topel M, Corrigan F, Kelli HM, Stahl E, Allard-Ratick M, Alkhoder A, Aida H, Gafeer MM, Hesaroieh I, Mahar E, Waller E, Vaccarino V, et al. CENTRAL OBESITY PREDICTS CIRCULATING PROGENITOR CELL LEVELS Journal of the American College of Cardiology. 69: 1789. DOI: 10.1016/S0735-1097(17)35178-1  0.128
2016 DeFilipp Z, Langston AA, Kota VK, Al-Kadhimi Z, Jillella AP, Waller EK, Khoury HJ. Tailored Post-Transplant Maintenance with Tyrosine Kinase Inhibitors for High-Risk Philadelphia Chromosome-Positive Leukemia Biology of Blood and Marrow Transplantation. 22: S313. DOI: 10.1016/J.BBMT.2015.11.785  0.128
2018 Song DJ, Gandelman JS, Chen Y, Clark WB, Engelhardt BG, Giver CR, Waller EK, Jagasia M. High Completion Rate of ECP Treatment in Patients with Chronic Graft-Versus-Host Disease Despite Unique Barriers: Lessons Learned From a Prospective Multicenter Trial Biology of Blood and Marrow Transplantation. 24: S306-S307. DOI: 10.1016/j.bbmt.2017.12.312  0.125
2007 Hossain M, Roback J, Pollack B, Jaye D, Waller E. 348: Chronic GvHD decreases anti-CMV immune responses in allogeneic BMT Biology of Blood and Marrow Transplantation. 13: 126. DOI: 10.1016/j.bbmt.2006.12.353  0.125
2004 Langston AA, McMillan S, Lonial S, Smith K, Waller EK, Heffner LT, Bucur S, Redei I, Flowers C, Lechowicz MJ, Winton E. A Phase I Trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg®) for Advanced MDS and Secondary or Relapsed AML. Blood. 104: 1814-1814. DOI: 10.1182/blood.v104.11.1814.1814  0.124
2020 Owonikoko TK, Dwivedi B, Chen Z, Zhang C, Barwick B, Gilbert-Ross M, Ernani V, Barwick B, Zhang G, Carlisle JW, Khuri FR, Curran WJ, Lonial S, Ramalingam SS, Sun S, ... Waller EK, et al. YAP1 positive small-cell lung cancer subtype is associated with the T-cell inflamed gene expression profile and confers good prognosis and long term survival. Journal of Clinical Oncology. 38: 9019-9019. DOI: 10.1200/Jco.2020.38.15_Suppl.9019  0.123
2017 Samman Tahhan A, Hammadah M, Sandesara PB, Hayek SS, Kalogeropoulos AP, Alkhoder A, Mohamed Kelli H, Topel M, Ghasemzadeh N, Chivukula K, Ko YA, Aida H, Hesaroieh I, Mahar E, Kim JH, ... ... Waller EK, et al. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure. Circulation. Heart Failure. 10. PMID 28790053 DOI: 10.1161/Circheartfailure.117.004106  0.122
2019 Giver CR, Shaw PA, Fletcher H, Kaushal D, Pamela G, Omoyege D, Bisson G, Gumbo T, Wallis R, Waller EK, Kalman D. IMPACT-TB*: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. *Imatinib Mesylate per Oral As a Clinical Therapeutic for TB Blood. 134: 1050-1050. DOI: 10.1182/Blood-2019-130275  0.122
2019 Chandrasekaran S, Sasaki M, Scharer CD, Kissick HT, Patterson DG, Magliocca KR, Seykora JT, Sapkota B, Gutman DA, Cooper LA, Lesinski GB, Waller EK, Thomas SN, Kotenko SV, Boss JM, et al. Phosphoinositide 3-kinase signaling can modulate MHC class I and II expression. Molecular Cancer Research : McR. PMID 31548239 DOI: 10.1158/1541-7786.MCR-19-0545  0.121
2018 Hammadah M, Samman Tahhan A, Mheid IA, Wilmot K, Ramadan R, Kindya BR, Kelli HM, O'Neal WT, Sandesara P, Sullivan S, Almuwaqqat Z, Obideen M, Abdelhadi N, Alkhoder A, Pimple PM, ... ... Waller EK, et al. Myocardial Ischemia and Mobilization of Circulating Progenitor Cells. Journal of the American Heart Association. 7: e007504. PMID 31898922 DOI: 10.1161/Jaha.117.007504  0.121
2020 Almuwaqqat Z, Kim JH, Hammadah M, Islam S, Lima BB, Hesaroieh I, Mokhtari A, LEVANTSEVYCH O, Ejaz K, Shah AJ, Bremner JD, Waller E, Vaccarino V, QUYYUMI AA. Abstract P537: Reduced Cardiovascular Regenerative Capacity is Associated With Enhanced Inflammatory Response to Acute Psychological Stress Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P537  0.121
2011 Rauf M, Gleason C, Nooka AK, Husman A, Waller EK. Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report. Journal of Medical Case Reports. 5: 372. PMID 21838907 DOI: 10.1186/1752-1947-5-372  0.121
2011 Josephson CD, Castillejo MI, Caliendo AM, Waller EK, Zimring J, Easley KA, Kutner M, Hillyer CD, Roback JD. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfusion Medicine Reviews. 25: 125-32. PMID 21345642 DOI: 10.1016/j.tmrv.2010.11.004  0.12
2015 Hsieh J, Ng S, Bosinger S, Wu JH, Tharp GK, Garcia A, Hossain MS, Yuan S, Waller EK, Galipeau J. A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency. Clinical & Translational Immunology. 4: e37. PMID 26131365 DOI: 10.1038/cti.2015.8  0.12
2020 Dhindsa D, Sandesara P, Jin Q, Liu C, Mehta A, Alkhoder A, Tahhan AS, Mokhtari A, Hesaroieh I, Waller E, Sperling LS, Quyyumi AA. THE COMBINATION OF HEMATOPOIETIC AND ENDOTHELIAL PROGENITOR CELLS IMPROVES PREDICTION OF OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 75: 162. DOI: 10.1016/s0735-1097(20)30789-0  0.116
2018 Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller JS, Blazar BR, Weisdorf DJ. Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples. Bone Marrow Transplantation. PMID 29515246 DOI: 10.1038/S41409-018-0127-3  0.115
2005 Langston AA, Heffner LT, Hutcherson D, Neely J, Flowers C, Waller EK, Lonial S, Khoury HJ, Winton E. Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen. Blood. 106: 4634-4634. DOI: 10.1182/blood.v106.11.4634.4634  0.115
2019 Koff JL, Waller EK. Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin? Cancer. PMID 30624770 DOI: 10.1002/cncr.31963  0.115
2014 Howard A, Chitphakdithai P, Waller EK, Harris W, Rosenthal H, Nelson W, Majhail N, Navarro W, Waldvogel S, Lisy J, Uecker J, Miller J, Spellman SR. Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services. Transfusion. 54: 1501-7. PMID 24383419 DOI: 10.1111/trf.12533  0.114
2003 Lonial S, Waller EK, Simons JW, Heffner LT. Signal transduction and myeloma: new targets, new hope. Cancer Biology & Therapy. 2: 310-9. PMID 14508098 DOI: 10.4161/cbt.2.4.425  0.114
2019 Mascaro JS, Waller AV, Wright L, Leonard T, Haack C, Waller EK. Individualized, Single Session Yoga Therapy to Reduce Physical and Emotional Symptoms in Hospitalized Hematological Cancer Patients. Integrative Cancer Therapies. 18: 1534735419861692. PMID 31311341 DOI: 10.1177/1534735419861692  0.114
2009 Hutcherson D, Surati M, Sanvidge K, Harvey D, Al-Baldawi R, Langston A, Flowers C, Lonial S, Kaufman J, Lechowicz M, Waller E. Pharmacokinetic (PK) Comparison Of Intravenous Versus Oral Busulfan Conditioning Regimens for Acute Myeloid Leukemia (AML) And Myelodysplastic Syndrome (MDS) Patients Biology of Blood and Marrow Transplantation. 15: 154-155. DOI: 10.1016/j.bbmt.2008.12.481  0.113
1994 Wilder RB, McGann JK, Sutherland WR, Waller EK, Minchinton AI, Goris ML, Knox SJ. The hypoxic cytotoxin sr 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts International Journal of Radiation Oncology, Biology, Physics. 28: 119-126. PMID 8270432 DOI: 10.1016/0360-3016(94)90149-X  0.113
2011 Bouchentouf M, Forner K, Cuerquis J, Boulassel MR, Routy JP, Waller EK, Quyyumi AA, Paradis P, Schiffrin EL, Galipeau J. A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease Cell Transplantation. 20: 1431-1443. PMID 21294961 DOI: 10.3727/096368910X557164  0.113
2017 Topel ML, Hayek SS, Ko YA, Sandesara PB, Samman Tahhan A, Hesaroieh I, Mahar E, Martin GS, Waller EK, Quyyumi AA. Sex Differences in Circulating Progenitor Cells. Journal of the American Heart Association. 6. PMID 28974500 DOI: 10.1161/JAHA.117.006245  0.112
2004 Waller E, Rosenthal H, Taylor K, Li J, Jaye D. Identification of Peptide Sequences That Selectively Bind Type 2 Dendritic Cells and a Subset of Plasmacytoid Dendritic Cell-Related Acute Myelogenous Leukemia: Implications for Immunotherapy Journal of Immunotherapy. 27: S6-S7. DOI: 10.1097/00002371-200411000-00027  0.111
2015 Hayek SS, Poole JC, Neuman R, Morris AA, Khayata M, Kavtaradze N, Topel ML, Binongo JG, Li Q, Jones DP, Waller EK, Quyyumi AA. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. Journal of the American Society of Hypertension : Jash. 9: 206-13. PMID 25681236 DOI: 10.1016/j.jash.2014.12.013  0.11
1999 Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells Journal of Biological Chemistry. 274: 19587-19592. PMID 10391893 DOI: 10.1074/jbc.274.28.19587  0.108
2017 Sandesara P, Tahhan AS, Khambhati J, Stahl E, Hayek S, Hammadah M, Mohamed Kelli H, Topel M, Alkhoder A, Chivukula K, Aida H, Gafeer MM, Abdelhadi N, Hesaroieh I, Naqvi H, ... ... Waller E, et al. ASSOCIATION BETWEEN CIRCULATING PROGENITOR CELLS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 69: 60. DOI: 10.1016/S0735-1097(17)33449-6  0.108
2015 Cohen JB, Bucur S, Winton EF, Sinha R, Heffner LT, King N, Lonial S, Langston AA, Waller EK, Hutchison-Rzepka A, Colbert A, Lechowicz MJ, Flowers CR. Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Clinical Lymphoma, Myeloma and Leukemia. 15: 514-518. DOI: 10.1016/j.clml.2015.06.009  0.107
2017 Sandesara PB, Ramjee V, Ghasemzadeh N, Guo Y, Bhatia N, Li Q, Vaughn L, Nell-Dybdahl C, Waller EK, Mahar EA, Brigham K, Wilson PWF, Quyyumi A, Le NA, Sperling LS. Circulating progenitor cells in patients with familial hypercholesterolemia. Journal of Clinical Apheresis. PMID 29114919 DOI: 10.1002/jca.21601  0.107
2016 Hayek SS, MacNamara J, Tahhan AS, Awad M, Yadalam A, Ko YA, Healy S, Ghaini I, Ahmed H, Gray B, Sher S, Ghasemzadeh N, Patel RS, Kim J, Waller EK, et al. Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease. Circulation Research. PMID 27267067 DOI: 10.1161/CIRCRESAHA.116.308802  0.107
2009 Subramaniyam V, Waller EK, Murrow JR, Manatunga A, Lonial S, Kasirajan K, Sutcliffe D, Harris W, Taylor WR, Alexander RW, Quyyumi AA. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. American Heart Journal. 158: 53-60.e1. PMID 19540392 DOI: 10.1016/J.Ahj.2009.04.014  0.106
2017 Waller EK. Mobilizing plasmacytoid dendritic cells. Blood. 129: 2600-2602. PMID 28495926 DOI: 10.1182/blood-2017-03-774703  0.105
2016 Hammadah M, Al Mheid I, Wilmot K, Ramadan R, Abdulhadi N, Alkhoder A, Obideen M, Pimple P, Levantsevych O, Kelli H, Shah A, Sun Y, Pearce B, Kutner M, Long Q, ... ... Waller E, et al. Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes. Circulation Research. PMID 27956416 DOI: 10.1161/Circresaha.116.309421  0.104
2018 Islam M, Mezencev R, McFarland B, Brink H, Campbell B, Tasadduq B, Waller EK, Lam W, Alexeev A, Sulchek T. Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy. Cell Death & Disease. 9: 239. PMID 29445159 DOI: 10.1038/S41419-018-0266-X  0.104
2015 Hayek SS, Neuman R, Kavtaradze N, Sher S, Jones D, Li Q, Zhao L, Chen SC, Waller E, Quyyumi A. Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis. International Journal of Cardiology. 182: 387-9. PMID 25617605 DOI: 10.1016/j.ijcard.2014.12.093  0.103
2014 Mitri Z, Siddiqui MT, El Rassi F, Holden JT, Heffner LT, Langston A, Waller EK, Winton E, McLemore M, Bernal-Mizrachi L, Jaye D, Arellano M, Khoury HJ. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leukemia & Lymphoma. 55: 1498-500. PMID 24134778 DOI: 10.3109/10428194.2013.852667  0.101
2006 Waller EK. Dendritic cells get VIP treatment Blood. 107: 3423-3424. DOI: 10.1182/blood-2006-02-001974  0.101
2017 Tahhan AS, Sandesara P, Hayek S, Hammadah M, Allard-Ratick M, Kindya B, Kalogeropoulos A, Kelli HM, Topel M, Alkhoder A, Chivukula K, Aida H, Gafeer MM, Stahl E, Robert H, ... ... Waller E, et al. PROGENITOR CELLS AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE Journal of the American College of Cardiology. 69: 928. DOI: 10.1016/S0735-1097(17)34317-6  0.101
2018 Rashidi A, Shanley R, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ. Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD. Bone Marrow Transplantation. PMID 30171221 DOI: 10.1038/S41409-018-0331-1  0.101
2015 Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, ... ... Waller EK, et al. New cancers after autotransplantations for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 738-45. PMID 25555448 DOI: 10.1016/j.bbmt.2014.12.028  0.1
2014 Ghasemzadeh N, Zhang L, Al Mheid I, Li Q, Sperling L, Waller EK, Taylor WR, Guest J, Quyyumi AA, Mavromatis K. Circulating progenitor cells are reduced in HIV-positive, anti-retroviral naïve patients. International Journal of Cardiology. 176: 1150-2. PMID 25175523 DOI: 10.1016/j.ijcard.2014.07.282  0.099
2009 Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults Autoimmunity Reviews. 9: 62-66. PMID 19293004 DOI: 10.1016/J.Autrev.2009.03.006  0.098
2017 Tahhan AS, Almuwaqqat Z, Sandesara P, Alkhoder A, Stahl E, Heinl R, Hayek S, Kelli HM, Hammadah M, Topel M, Gafeer MM, Chivukula K, Aida H, Allard-Ratick M, Kindya B, ... ... Waller E, et al. CIRCULATING PROGENITOR CELLS LEVELS AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION Journal of the American College of Cardiology. 69: 288. DOI: 10.1016/S0735-1097(17)33677-X  0.096
2016 Hajjar I, Goldstein FC, Waller EK, Moss LD, Quyyumi A. Circulating Progenitor Cells is Linked to Cognitive Decline in Healthy Adults. The American Journal of the Medical Sciences. 351: 147-52. PMID 26897269 DOI: 10.1016/j.amjms.2015.11.009  0.094
2020 Waller EK. A new role for an old cytokine: GM-CSF amplifies GVHD. Blood. 135: 520-521. PMID 32078687 DOI: 10.1182/blood.2019004681  0.093
2014 Al Mheid I, Corrigan F, Shirazi F, Veledar E, Li Q, Alexander WR, Taylor WR, Waller EK, Quyyumi AA. Circadian variation in vascular function and regenerative capacity in healthy humans. Journal of the American Heart Association. 3: e000845. PMID 24830296 DOI: 10.1161/JAHA.114.000845  0.093
1985 Fisher R, Waller EK, Grossi G, Thompson D, Tizard R, Schleuning WD. Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region Journal of Biological Chemistry. 260: 11223-11230. PMID 3161893  0.092
1986 Hettle JA, Waller EK, Fritz IB. Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells Biology of Reproduction. 34: 895-904. PMID 3730484  0.09
2016 Hayek S, Ko Y, Mheid IA, Hosny K, Ahmed H, Gray B, Patel K, Hesaroieh I, Martin G, Kim J, Waller E, Quyyumi A. VITAMIN D3 LEVELS MODULATE CXCR4+ CIRCULATING PROGENITOR CELL COUNTS Journal of the American College of Cardiology. 67: 2027. DOI: 10.1016/S0735-1097(16)32028-9  0.087
2014 Patel S, Ghasemzadeh N, Patel R, Li Q, Eapen D, Khayata M, Malekzadegan M, Smith G, Barde R, Awad M, Reddy S, Sperling L, Waller E, Quyyumi A. CIRCULATING PROGENITOR CELL LEVELS ARE HIGHER IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION COMPARED TO OTHER ACUTE CORONARY SYNDROME PRESENTATIONS Journal of the American College of Cardiology. 63: A69. DOI: 10.1016/S0735-1097(14)60069-3  0.086
2011 Giver CR, Jaye DL, Waller EK, Kaufman JL, Lonial S. Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes. Leukemia. 25: 362-5. PMID 21109772 DOI: 10.1038/leu.2010.262  0.086
2014 El Rassi F, Ward KC, Flowers CR, Heffner LT, Waller EK, Winton EF, Vaughn J, Hill BG, Langston A, Nooka A, Arellano M, Khoury HJ. Incidence and geographic distribution of adult acute leukemia in the state of Georgia. Southern Medical Journal. 107: 497-500. PMID 25084186 DOI: 10.14423/SMJ.0000000000000146  0.086
2019 Moazzami K, Wittbrodt MT, Lima BB, Kim JH, Hammadah M, Ko YA, Obideen M, Abdelhadi N, Kaseer B, Gafeer MM, Nye JA, Shah AJ, Ward L, Raggi P, Waller EK, et al. Circulating Progenitor Cells and Memory Function in Patients with Coronary Artery Disease. Journal of Alzheimer's Disease : Jad. PMID 31476151 DOI: 10.3233/Jad-190217  0.085
2016 Mekonnen G, Hayek SS, Mehta PK, Li Q, Mahar E, Mou L, Kenkre TS, Petersen JW, Azarbal B, Samuels B, Anderson RD, Sedlak T, Zaya M, Agarwal M, Haftbaradaran A, ... ... Waller EK, et al. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD). Atherosclerosis. 253: 111-117. PMID 27596135 DOI: 10.1016/j.atherosclerosis.2016.08.026  0.085
2020 Islam SJ, Kim JH, Topel M, Liu C, Ko YA, Mujahid MS, Sims M, Mubasher M, Ejaz K, Morgan-Billingslea J, Jones K, Waller EK, Jones D, Uppal K, Dunbar SB, et al. Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study. Journal of the American Heart Association. e015247. PMID 32340530 DOI: 10.1161/Jaha.119.015247  0.085
2011 August KJ, Chiang KY, Bostick RM, Flanders WD, Waller EK, Langston A, Worthington-White D, Rowland P, Moore KF, Khoury HJ, Horan JT. Biomarkers of immune activation to screen for severe, acute GVHD. Bone Marrow Transplantation. 46: 601-4. PMID 20622904 DOI: 10.1038/bmt.2010.165  0.085
2012 Rassi FE, Mitri Z, Heffner LT, Langston A, Waller EK, Winton EF, McLemore ML, Bernal L, Arellano M, Khoury HJ. Cerebrospinal Fluid Flow Cytometry in Acute Lymphoblastic Leukemia/Lymphoma: Is It Beneficial?. Blood. 120: 2576-2576. DOI: 10.1182/blood.v120.21.2576.2576  0.081
2020 Moazzami K, Wittbrodt MT, Lima BB, Kim JH, Hammadah M, Ko YA, Obideen M, Abdelhadi N, Kaseer B, Gafeer MM, Nye JA, Shah AJ, Ward L, Raggi P, Waller EK, et al. Circulating Progenitor Cells and Cognitive Impairment in Men and Women with Coronary Artery Disease. Journal of Alzheimer's Disease : Jad. PMID 32083582 DOI: 10.3233/Jad-191063  0.08
2015 Hassan MN, Waller EK. Treating chemotherapy-induced thrombocytopenia: is it time for oncologists to use thrombopoietin agonists? Oncology (Williston Park, N.Y.). 29: 295-6. PMID 25952493  0.079
1998 Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor Blood. 91: 4427-4433. PMID 9616135 DOI: 10.1182/Blood.V91.12.4427.412K44_4427_4433  0.078
2016 Nickel RS, Waller EK, Qayed M, Chiang KY. Clinically significant adverse events after major ABO mismatch BMT Bone Marrow Transplantation. 51: 148-149. DOI: 10.1038/bmt.2015.230  0.076
2012 Lill M, Lim S, Yeh R, Waller E, Costa L, Shore T, Craig M, Freytes C, Shea T, Mineishi S, Rondelli D, Horwitz M, Braunschweig I, Fay J, Mason J, et al. Dose Precision Using a Pretransplant Test PK of Intravenous Busulfan Prior to BuCyVP-16 Preparative Regimen in Lymphoma Biology of Blood and Marrow Transplantation. 18: S246. DOI: 10.1016/J.Bbmt.2011.12.126  0.075
1989 Waller E. Conservation & Land Reclamation on the Urban Fringe With Special Referene to the Jeddah Area, Saudi Arabia Journal of King Abdulaziz University-Engineering Sciences. 1: 65-77. DOI: 10.4197/eng.1-1.6  0.072
2020 Harvey RD, Carthon BC, Lewis C, Hossain MS, Zhang C, Chen Z, Harris WB, Alese OB, Shaib W, Bilen MA, Lawson DH, Wu C, Steuer CE, El-Rayes BF, Khuri FR, ... ... Waller EK, et al. Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British Journal of Cancer. PMID 32704173 DOI: 10.1038/S41416-020-0988-2  0.07
2013 Bethelmie-Bryan B, Lord K, Holloway S, Safavi F, Shepard M, Rogers S, Harvey RD, Rodger K, Waller EK, El-Rayes B, Arellano M, Khoury HJ. Tools to optimize the functionality of a leukemia clinical trial team. Leukemia & Lymphoma. 54: 110-6. PMID 22762552 DOI: 10.3109/10428194.2012.708929  0.068
2012 Giver CR, Jaye DL, Waller EK, Lonial S. Recovery and rebound of platelet counts in mice after thrombocytopenia induced by combination bortezomib + romidepsin. Experimental Hematology. 40: 95-6. PMID 22101254 DOI: 10.1016/j.exphem.2011.11.002  0.067
2004 Rosenthal H, Jaye D, Cherry E, Waller E. Isolation and functional inhibitory affects of specific peptides bound to type 2 dendritic cells (DC2) Biology of Blood and Marrow Transplantation. 10: 16-17. DOI: 10.1016/j.bbmt.2003.12.058  0.067
2012 El Rassi F, Arellano M, Heffner LT, Waller EK, Winton EF, Ward K, Khoury HJ. Incidence and Geographic Distribution of Adult Acute Lymphoblastic Leukemia in the State of Georgia Blood. 120: 4309-4309. DOI: 10.1182/blood.V120.21.4309.4309  0.067
2011 Li J, Hossain S, Wang Y, Fan K, Harris W, Waschek J, Waller E. Cellular Anti-Viral Immune Responses Are Increased in the Absence of Vasoactive Intestinal Peptide Biology of Blood and Marrow Transplantation. 17: S154. DOI: 10.1016/J.Bbmt.2010.12.014  0.062
2020 Mehta A, Tahhan AS, Liu C, Dhindsa D, Nayak A, Hooda A, Moazzami K, Islam S, Rogers S, Almuwaqqat Z, Hesaroieh I, Mokhtari A, Ko Y, Waller E, Quyyumi AA. IMPAIRED REGENERATIVE CAPACITY PREDICTS OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE AND RENAL INSUFFICIENCY Journal of the American College of Cardiology. 75: 3660. DOI: 10.1016/s0735-1097(20)34287-x  0.058
1985 Rajput B, Degen SF, Reich E, Waller EK, Axelrod J, Eddy RL, Shows TB. Chromosomal locations of human tissue plasminogen activator and urokinase genes. Science (New York, N.Y.). 230: 672-4. PMID 3840278 DOI: 10.1126/science.3840278  0.057
2016 Al Mheid I, Hayek SS, Ko YA, Akbik F, Li Q, Ghasemzadeh N, Martin G, Long Q, Hammadah M, Zafari AM, Vaccarino V, Waller EK, Quyyumi AA. Age and Human Regenerative Capacity: Impact of Cardiovascular Risk Factors. Circulation Research. PMID 27436845 DOI: 10.1161/Circresaha.116.308461  0.054
2008 Pentz RD, Xu Z, Lonial S, Kauh JS, O'Regan RM, Waller EK, Shin DM, Fu H, Khuri F. Research participants' views of nontherapeutic biopsies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 13529. PMID 27949039 DOI: 10.1200/Jco.2008.26.15_Suppl.13529  0.049
2017 Lee EK, Beeler T, Bhardwaj A, Bao B, Pang J, Wang Y, Langston AA, Lonial S, Waller EK. Improving Patient Care Through Clinical Process Optimization Biology of Blood and Marrow Transplantation. 23: S412-S413. DOI: 10.1016/j.bbmt.2016.12.498  0.048
2013 Owonikoko TK, Hossain MS, Bhimani C, Chen Z, Kim S, Ramalingam SS, Sun SY, Shin DM, Waller EK, Khuri FR. Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer. 119: 1503-11. PMID 23340930 DOI: 10.1002/Cncr.27937  0.042
2014 Hutcherson D, Valla K, Shah KS, Surati M, French K, Nooka A, Kaufman J, Lonial S, Cohen JB, Langston A, Lechowicz M, Flowers C, Waller EK. Simplified Technique for Administration of High Dose Melphalan Biology of Blood and Marrow Transplantation. 20: S291-S292. DOI: 10.1016/j.bbmt.2013.12.492  0.041
1983 Waller EK, Schleuning WD, Reich E. Complex-formation and inhibition of urokinase by blood plasma proteins Biochemical Journal. 215: 123-131. PMID 6194790  0.04
2019 Woods A, Wooten M, Thompson Heffner L, Waller E. Daratumumab-associated hemophagocytic lymphohistiocytosis. Annals of Hematology. PMID 31844932 DOI: 10.1007/s00277-019-03877-7  0.039
2011 Murrow J, Esteves F, Galt J, Chen J, Garcia E, Lin J, Lerakis S, Sher S, Khan Pohlel F, Waller EK, Vaughan D, Perin E, Willerson J, Kereiakes D, Preti R, et al. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 18: 912-9. PMID 21717276 DOI: 10.1007/S12350-011-9414-8  0.037
Hide low-probability matches.